| A06.4 | Amebic liver abscess |
| A15.0 | Tuberculosis of lung |
| A15.4 | Tuberculosis of intrathoracic lymph nodes |
| A15.5 | Tuberculosis of larynx, trachea and bronchus |
| A15.6 | Tuberculous pleurisy |
| A15.7 | Primary respiratory tuberculosis |
| A15.8 | Other respiratory tuberculosis |
| A15.9 | Respiratory tuberculosis unspecified |
| A17.0 | Tuberculous meningitis |
| A17.1 | Meningeal tuberculoma |
| A17.8 | Other tuberculosis of nervous system |
| A17.81 | Tuberculoma of brain and spinal cord |
| A17.82 | Tuberculous meningoencephalitis |
| A17.83 | Tuberculous neuritis |
| A17.89 | Other tuberculosis of nervous system |
| A17.9 | Tuberculosis of nervous system, unspecified |
| A18.0 | Tuberculosis of bones and joints |
| A18.01 | Tuberculosis of spine |
| A18.02 | Tuberculous arthritis of other joints |
| A18.03 | Tuberculosis of other bones |
| A18.09 | Other musculoskeletal tuberculosis |
| A18.1 | Tuberculosis of genitourinary system |
| A18.10 | Tuberculosis of genitourinary system, unspecified |
| A18.11 | Tuberculosis of kidney and ureter |
| A18.12 | Tuberculosis of bladder |
| A18.13 | Tuberculosis of other urinary organs |
| A18.14 | Tuberculosis of prostate |
| A18.15 | Tuberculosis of other male genital organs |
| A18.16 | Tuberculosis of cervix |
| A18.17 | Tuberculous female pelvic inflammatory disease |
| A18.18 | Tuberculosis of other female genital organs |
| A18.2 | Tuberculous peripheral lymphadenopathy |
| A18.3 | Tuberculosis of intestines, peritoneum and mesenteric glands |
| A18.31 | Tuberculous peritonitis |
| A18.32 | Tuberculous enteritis |
| A18.39 | Retroperitoneal tuberculosis |
| A18.4 | Tuberculosis of skin and subcutaneous tissue |
| A18.5 | Tuberculosis of eye |
| A18.50 | Tuberculosis of eye, unspecified |
| A18.51 | Tuberculous episcleritis |
| A18.52 | Tuberculous keratitis |
| A18.53 | Tuberculous chorioretinitis |
| A18.54 | Tuberculous iridocyclitis |
| A18.59 | Other tuberculosis of eye |
| A18.6 | Tuberculosis of (inner) (middle) ear |
| A18.7 | Tuberculosis of adrenal glands |
| A18.8 | Tuberculosis of other specified organs |
| A18.81 | Tuberculosis of thyroid gland |
| A18.82 | Tuberculosis of other endocrine glands |
| A18.83 | Tuberculosis of digestive tract organs, not elsewhere classified |
| A18.84 | Tuberculosis of heart |
| A18.85 | Tuberculosis of spleen |
| A18.89 | Tuberculosis of other sites |
| A19.0 | Acute miliary tuberculosis of a single specified site |
| A19.1 | Acute miliary tuberculosis of multiple sites |
| A19.2 | Acute miliary tuberculosis, unspecified |
| A19.8 | Other miliary tuberculosis |
| A19.9 | Miliary tuberculosis, unspecified |
| A31.0 | Pulmonary mycobacterial infection |
| A31.1 | Cutaneous mycobacterial infection |
| A31.2 | Disseminated mycobacterium avium-intracellulare complex (DMAC) |
| A31.8 | Other mycobacterial infections |
| A31.9 | Mycobacterial infection, unspecified |
| A51.45 | Secondary syphilitic hepatitis |
| A52.04 | Syphilitic cerebral arteritis |
| B00.81 | Herpesviral hepatitis |
| B02.0 | Zoster encephalitis |
| B02.1 | Zoster meningitis |
| B02.2 | Zoster with other nervous system involvement |
| B02.21 | Postherpetic geniculate ganglionitis |
| B02.22 | Postherpetic trigeminal neuralgia |
| B02.23 | Postherpetic polyneuropathy |
| B02.24 | Postherpetic myelitis |
| B02.29 | Other postherpetic nervous system involvement |
| B02.3 | Zoster ocular disease |
| B02.30 | Zoster ocular disease, unspecified |
| B02.31 | Zoster conjunctivitis |
| B02.32 | Zoster iridocyclitis |
| B02.33 | Zoster keratitis |
| B02.34 | Zoster scleritis |
| B02.39 | Other herpes zoster eye disease |
| B02.7 | Disseminated zoster |
| B02.8 | Zoster with other complications |
| B02.9 | Zoster without complications |
| B15.0 | Hepatitis A with hepatic coma |
| B15.9 | Hepatitis A without hepatic coma |
| B16.0 | Acute hepatitis B with delta-agent with hepatic coma |
| B16.1 | Acute hepatitis B with delta-agent without hepatic coma |
| B16.2 | Acute hepatitis B without delta-agent with hepatic coma |
| B16.9 | Acute hepatitis B without delta-agent and without hepatic coma |
| B17.0 | Acute delta-(super) infection of hepatitis B carrier |
| B17.1 | Acute hepatitis C |
| B17.10 | Acute hepatitis C without hepatic coma |
| B17.11 | Acute hepatitis C with hepatic coma |
| B17.2 | Acute hepatitis E |
| B17.8 | Other specified acute viral hepatitis |
| B17.9 | Acute viral hepatitis, unspecified |
| B18.0 | Chronic viral hepatitis B with delta-agent |
| B18.1 | Chronic viral hepatitis B without delta-agent |
| B18.2 | Chronic viral hepatitis C |
| B18.8 | Other chronic viral hepatitis |
| B18.9 | Chronic viral hepatitis, unspecified |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.1 | Unspecified viral hepatitis B |
| B19.10 | Unspecified viral hepatitis B without hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.2 | Unspecified viral hepatitis C |
| B19.20 | Unspecified viral hepatitis C without hepatic coma |
| B19.21 | Unspecified viral hepatitis C with hepatic coma |
| B19.9 | Unspecified viral hepatitis without hepatic coma |
| B25.1 | Cytomegaloviral hepatitis |
| B26.81 | Mumps hepatitis |
| B58.1 | Toxoplasma hepatitis |
| B90.0 | Sequelae of central nervous system tuberculosis |
| B90.1 | Sequelae of genitourinary tuberculosis |
| B90.2 | Sequelae of tuberculosis of bones and joints |
| B90.8 | Sequelae of tuberculosis of other organs |
| B90.9 | Sequelae of respiratory and unspecified tuberculosis |
| B94.2 | Sequelae of viral hepatitis |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.2 | Hepatoblastoma |
| C22.3 | Angiosarcoma of liver |
| C22.4 | Other sarcomas of liver |
| C22.7 | Other specified carcinomas of liver |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C24.1 | Malignant neoplasm of ampulla of Vater |
| C24.8 | Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 | Malignant neoplasm of biliary tract, unspecified |
| C77.0 | Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck |
| C77.1 | Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes |
| C77.2 | Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes |
| C77.3 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C77.4 | Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes |
| C77.5 | Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct |
| C7B.02 | Secondary carcinoid tumors of liver |
| C82.0 | Follicular lymphoma grade I |
| C82.00 | Follicular lymphoma grade I, unspecified site |
| C82.01 | Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 | Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 | Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 | Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 | Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 | Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 | Follicular lymphoma grade I, spleen |
| C82.08 | Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 | Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.1 | Follicular lymphoma grade II |
| C82.10 | Follicular lymphoma grade II, unspecified site |
| C82.11 | Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 | Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 | Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 | Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 | Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 | Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 | Follicular lymphoma grade II, spleen |
| C82.18 | Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 | Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.2 | Follicular lymphoma grade III, unspecified |
| C82.20 | Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 | Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 | Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 | Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 | Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 | Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 | Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 | Follicular lymphoma grade III, unspecified, spleen |
| C82.28 | Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 | Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.3 | Follicular lymphoma grade IIIa |
| C82.30 | Follicular lymphoma grade IIIa, unspecified site |
| C82.31 | Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 | Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 | Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 | Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 | Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 | Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 | Follicular lymphoma grade IIIa, spleen |
| C82.38 | Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 | Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.4 | Follicular lymphoma grade IIIb |
| C82.40 | Follicular lymphoma grade IIIb, unspecified site |
| C82.41 | Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 | Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 | Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 | Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 | Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 | Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 | Follicular lymphoma grade IIIb, spleen |
| C82.48 | Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 | Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.5 | Diffuse follicle center lymphoma |
| C82.50 | Diffuse follicle center lymphoma, unspecified site |
| C82.51 | Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 | Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 | Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 | Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 | Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 | Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 | Diffuse follicle center lymphoma, spleen |
| C82.58 | Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 | Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.6 | Cutaneous follicle center lymphoma |
| C82.60 | Cutaneous follicle center lymphoma, unspecified site |
| C82.61 | Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 | Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 | Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 | Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 | Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 | Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 | Cutaneous follicle center lymphoma, spleen |
| C82.68 | Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 | Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.8 | Other types of follicular lymphoma |
| C82.80 | Other types of follicular lymphoma, unspecified site |
| C82.81 | Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 | Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 | Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 | Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 | Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 | Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 | Other types of follicular lymphoma, spleen |
| C82.88 | Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.9 | Follicular lymphoma, unspecified |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.91 | Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 | Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 | Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 | Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 | Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 | Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 | Follicular lymphoma, unspecified, spleen |
| C82.98 | Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.0 | Small cell B-cell lymphoma |
| C83.00 | Small cell B-cell lymphoma, unspecified site |
| C83.01 | Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 | Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 | Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 | Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 | Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 | Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 | Small cell B-cell lymphoma, spleen |
| C83.08 | Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 | Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.3 | Diffuse large B-cell lymphoma |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C83.31 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 | Diffuse large B-cell lymphoma, spleen |
| C83.38 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites |
| C83.5 | Lymphoblastic (diffuse) lymphoma |
| C83.50 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 | Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.7 | Burkitt lymphoma |
| C83.70 | Burkitt lymphoma, unspecified site |
| C83.71 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 | Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 | Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 | Burkitt lymphoma, spleen |
| C83.78 | Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 | Burkitt lymphoma, extranodal and solid organ sites |
| C83.8 | Other non-follicular lymphoma |
| C83.80 | Other non-follicular lymphoma, unspecified site |
| C83.81 | Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 | Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 | Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 | Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 | Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 | Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 | Other non-follicular lymphoma, spleen |
| C83.88 | Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 | Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.9 | Non-follicular (diffuse) lymphoma, unspecified |
| C83.90 | Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 | Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 | Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 | Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 | Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 | Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 | Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C85.1 | Unspecified B-cell lymphoma |
| C85.10 | Unspecified B-cell lymphoma, unspecified site |
| C85.11 | Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 | Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 | Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 | Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 | Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 | Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 | Unspecified B-cell lymphoma, spleen |
| C85.18 | Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 | Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.2 | Mediastinal (thymic) large B-cell lymphoma |
| C85.20 | Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 | Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 | Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 | Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 | Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 | Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 | Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.8 | Other specified types of non-Hodgkin lymphoma |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 | Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 | Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 | Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 | Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 | Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 | Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 | Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.9 | Non-Hodgkin lymphoma, unspecified |
| C85.90 | Non-Hodgkin lymphoma, unspecified, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C85.94 | Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C85.95 | Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C85.96 | Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C85.97 | Non-Hodgkin lymphoma, unspecified, spleen |
| C85.98 | Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C85.99 | Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C88.0 | Waldenstrom macroglobulinemia |
| C88.2 | Heavy chain disease |
| C88.3 | Immunoproliferative small intestinal disease |
| C88.4 | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] |
| C88.8 | Other malignant immunoproliferative diseases |
| C88.9 | Malignant immunoproliferative disease, unspecified |
| D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
| D13.0 | Benign neoplasm of esophagus |
| D13.1 | Benign neoplasm of stomach |
| D13.2 | Benign neoplasm of duodenum |
| D13.3 | Benign neoplasm of other and unspecified parts of small intestine |
| D13.30 | Benign neoplasm of unspecified part of small intestine |
| D13.39 | Benign neoplasm of other parts of small intestine |
| D13.4 | Benign neoplasm of liver |
| D13.5 | Benign neoplasm of extrahepatic bile ducts |
| D13.6 | Benign neoplasm of pancreas |
| D13.7 | Benign neoplasm of endocrine pancreas |
| D13.9 | Benign neoplasm of ill-defined sites within the digestive system |
| D37.6 | Neoplasm of uncertain behavior of liver, gallbladder and bile ducts |
| D69.0 | Allergic purpura |
| D69.1 | Qualitative platelet defects |
| D69.2 | Other nonthrombocytopenic purpura |
| D69.3 | Immune thrombocytopenic purpura |
| D69.4 | Other primary thrombocytopenia |
| D69.41 | Evans syndrome |
| D69.42 | Congenital and hereditary thrombocytopenia purpura |
| D69.49 | Other primary thrombocytopenia |
| D69.5 | Secondary thrombocytopenia |
| D69.51 | Posttransfusion purpura |
| D69.59 | Other secondary thrombocytopenia |
| D69.6 | Thrombocytopenia, unspecified |
| D69.8 | Other specified hemorrhagic conditions |
| D69.9 | Hemorrhagic condition, unspecified |
| D89.0 | Polyclonal hypergammaglobulinemia |
| D89.1 | Cryoglobulinemia |
| D89.2 | Hypergammaglobulinemia, unspecified |
| D89.3 | Immune reconstitution syndrome |
| D89.4 | Mast cell activation syndrome and related disorders |
| D89.40 | Mast cell activation, unspecified |
| D89.41 | Monoclonal mast cell activation syndrome |
| D89.42 | Idiopathic mast cell activation syndrome |
| D89.43 | Secondary mast cell activation |
| D89.49 | Other mast cell activation disorder |
| D89.8 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D89.81 | Graft-versus-host disease |
| D89.810 | Acute graft-versus-host disease |
| D89.811 | Chronic graft-versus-host disease |
| D89.812 | Acute on chronic graft-versus-host disease |
| D89.813 | Graft-versus-host disease, unspecified |
| D89.82 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D89.83 | Cytokine release syndrome |
| D89.831 | Cytokine release syndrome, grade 1 |
| D89.832 | Cytokine release syndrome, grade 2 |
| D89.833 | Cytokine release syndrome, grade 3 |
| D89.834 | Cytokine release syndrome, grade 4 |
| D89.835 | Cytokine release syndrome, grade 5 |
| D89.839 | Cytokine release syndrome, grade unspecified |
| D89.89 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D89.9 | Disorder involving the immune mechanism, unspecified |
| E10.40 | Type 1 diabetes mellitus with diabetic neuropathy, unspecified |
| E11.40 | Type 2 diabetes mellitus with diabetic neuropathy, unspecified |
| F11.1 | Opioid abuse |
| F11.10 | Opioid abuse, uncomplicated |
| F11.11 | Opioid abuse, in remission |
| F11.12 | Opioid abuse with intoxication |
| F11.120 | Opioid abuse with intoxication, uncomplicated |
| F11.121 | Opioid abuse with intoxication delirium |
| F11.122 | Opioid abuse with intoxication with perceptual disturbance |
| F11.129 | Opioid abuse with intoxication, unspecified |
| F11.13 | Opioid abuse with withdrawal |
| F11.14 | Opioid abuse with opioid-induced mood disorder |
| F11.15 | Opioid abuse with opioid-induced psychotic disorder |
| F11.150 | Opioid abuse with opioid-induced psychotic disorder with delusions |
| F11.151 | Opioid abuse with opioid-induced psychotic disorder with hallucinations |
| F11.159 | Opioid abuse with opioid-induced psychotic disorder, unspecified |
| F11.18 | Opioid abuse with other opioid-induced disorder |
| F11.181 | Opioid abuse with opioid-induced sexual dysfunction |
| F11.182 | Opioid abuse with opioid-induced sleep disorder |
| F11.188 | Opioid abuse with other opioid-induced disorder |
| F11.19 | Opioid abuse with unspecified opioid-induced disorder |
| F11.2 | Opioid dependence |
| F11.20 | Opioid dependence, uncomplicated |
| F11.21 | Opioid dependence, in remission |
| F11.22 | Opioid dependence with intoxication |
| F11.220 | Opioid dependence with intoxication, uncomplicated |
| F11.221 | Opioid dependence with intoxication delirium |
| F11.222 | Opioid dependence with intoxication with perceptual disturbance |
| F11.229 | Opioid dependence with intoxication, unspecified |
| F11.23 | Opioid dependence with withdrawal |
| F11.24 | Opioid dependence with opioid-induced mood disorder |
| F11.25 | Opioid dependence with opioid-induced psychotic disorder |
| F11.250 | Opioid dependence with opioid-induced psychotic disorder with delusions |
| F11.251 | Opioid dependence with opioid-induced psychotic disorder with hallucinations |
| F11.259 | Opioid dependence with opioid-induced psychotic disorder, unspecified |
| F11.28 | Opioid dependence with other opioid-induced disorder |
| F11.281 | Opioid dependence with opioid-induced sexual dysfunction |
| F11.282 | Opioid dependence with opioid-induced sleep disorder |
| F11.288 | Opioid dependence with other opioid-induced disorder |
| F11.29 | Opioid dependence with unspecified opioid-induced disorder |
| F11.9 | Opioid use, unspecified |
| F11.90 | Opioid use, unspecified, uncomplicated |
| F11.92 | Opioid use, unspecified with intoxication |
| F11.920 | Opioid use, unspecified with intoxication, uncomplicated |
| F11.921 | Opioid use, unspecified with intoxication delirium |
| F11.922 | Opioid use, unspecified with intoxication with perceptual disturbance |
| F11.929 | Opioid use, unspecified with intoxication, unspecified |
| F11.93 | Opioid use, unspecified with withdrawal |
| F11.94 | Opioid use, unspecified with opioid-induced mood disorder |
| F11.95 | Opioid use, unspecified with opioid-induced psychotic disorder |
| F11.950 | Opioid use, unspecified with opioid-induced psychotic disorder with delusions |
| F11.951 | Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations |
| F11.959 | Opioid use, unspecified with opioid-induced psychotic disorder, unspecified |
| F11.98 | Opioid use, unspecified with other specified opioid-induced disorder |
| F11.981 | Opioid use, unspecified with opioid-induced sexual dysfunction |
| F11.982 | Opioid use, unspecified with opioid-induced sleep disorder |
| F11.988 | Opioid use, unspecified with other opioid-induced disorder |
| F11.99 | Opioid use, unspecified with unspecified opioid-induced disorder |
| F12.1 | Cannabis abuse |
| F12.10 | Cannabis abuse, uncomplicated |
| F12.11 | Cannabis abuse, in remission |
| F12.12 | Cannabis abuse with intoxication |
| F12.120 | Cannabis abuse with intoxication, uncomplicated |
| F12.121 | Cannabis abuse with intoxication delirium |
| F12.122 | Cannabis abuse with intoxication with perceptual disturbance |
| F12.129 | Cannabis abuse with intoxication, unspecified |
| F12.13 | Cannabis abuse with withdrawal |
| F12.15 | Cannabis abuse with psychotic disorder |
| F12.150 | Cannabis abuse with psychotic disorder with delusions |
| F12.151 | Cannabis abuse with psychotic disorder with hallucinations |
| F12.159 | Cannabis abuse with psychotic disorder, unspecified |
| F12.18 | Cannabis abuse with other cannabis-induced disorder |
| F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
| F12.188 | Cannabis abuse with other cannabis-induced disorder |
| F12.19 | Cannabis abuse with unspecified cannabis-induced disorder |
| F12.2 | Cannabis dependence |
| F12.20 | Cannabis dependence, uncomplicated |
| F12.21 | Cannabis dependence, in remission |
| F12.22 | Cannabis dependence with intoxication |
| F12.220 | Cannabis dependence with intoxication, uncomplicated |
| F12.221 | Cannabis dependence with intoxication delirium |
| F12.222 | Cannabis dependence with intoxication with perceptual disturbance |
| F12.229 | Cannabis dependence with intoxication, unspecified |
| F12.23 | Cannabis dependence with withdrawal |
| F12.25 | Cannabis dependence with psychotic disorder |
| F12.250 | Cannabis dependence with psychotic disorder with delusions |
| F12.251 | Cannabis dependence with psychotic disorder with hallucinations |
| F12.259 | Cannabis dependence with psychotic disorder, unspecified |
| F12.28 | Cannabis dependence with other cannabis-induced disorder |
| F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
| F12.288 | Cannabis dependence with other cannabis-induced disorder |
| F12.29 | Cannabis dependence with unspecified cannabis-induced disorder |
| F12.9 | Cannabis use, unspecified |
| F12.90 | Cannabis use, unspecified, uncomplicated |
| F12.92 | Cannabis use, unspecified with intoxication |
| F12.920 | Cannabis use, unspecified with intoxication, uncomplicated |
| F12.921 | Cannabis use, unspecified with intoxication delirium |
| F12.922 | Cannabis use, unspecified with intoxication with perceptual disturbance |
| F12.929 | Cannabis use, unspecified with intoxication, unspecified |
| F12.93 | Cannabis use, unspecified with withdrawal |
| F12.95 | Cannabis use, unspecified with psychotic disorder |
| F12.950 | Cannabis use, unspecified with psychotic disorder with delusions |
| F12.951 | Cannabis use, unspecified with psychotic disorder with hallucinations |
| F12.959 | Cannabis use, unspecified with psychotic disorder, unspecified |
| F12.98 | Cannabis use, unspecified with other cannabis-induced disorder |
| F12.980 | Cannabis use, unspecified with anxiety disorder |
| F12.988 | Cannabis use, unspecified with other cannabis-induced disorder |
| F12.99 | Cannabis use, unspecified with unspecified cannabis-induced disorder |
| F13.1 | Sedative, hypnotic or anxiolytic-related abuse |
| F13.10 | Sedative, hypnotic or anxiolytic abuse, uncomplicated |
| F13.11 | Sedative, hypnotic or anxiolytic abuse, in remission |
| F13.12 | Sedative, hypnotic or anxiolytic abuse with intoxication |
| F13.120 | Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated |
| F13.121 | Sedative, hypnotic or anxiolytic abuse with intoxication delirium |
| F13.129 | Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified |
| F13.13 | Sedative, hypnotic or anxiolytic abuse with withdrawal |
| F13.130 | Sedative, hypnotic or anxiolytic abuse with withdrawal, uncomplicated |
| F13.131 | Sedative, hypnotic or anxiolytic abuse with withdrawal delirium |
| F13.132 | Sedative, hypnotic or anxiolytic abuse with withdrawal with perceptual disturbance |
| F13.139 | Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified |
| F13.14 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.15 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.150 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.151 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.159 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.18 | Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.180 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.181 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.182 | Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.188 | Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.19 | Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F13.2 | Sedative, hypnotic or anxiolytic-related dependence |
| F13.20 | Sedative, hypnotic or anxiolytic dependence, uncomplicated |
| F13.21 | Sedative, hypnotic or anxiolytic dependence, in remission |
| F13.22 | Sedative, hypnotic or anxiolytic dependence with intoxication |
| F13.220 | Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated |
| F13.221 | Sedative, hypnotic or anxiolytic dependence with intoxication delirium |
| F13.229 | Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified |
| F13.23 | Sedative, hypnotic or anxiolytic dependence with withdrawal |
| F13.230 | Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated |
| F13.231 | Sedative, hypnotic or anxiolytic dependence with withdrawal delirium |
| F13.232 | Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance |
| F13.239 | Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified |
| F13.24 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.25 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.250 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.251 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.259 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.26 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder |
| F13.27 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia |
| F13.28 | Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.280 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.281 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.282 | Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.288 | Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.29 | Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F13.9 | Sedative, hypnotic or anxiolytic-related use, unspecified |
| F13.90 | Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated |
| F13.92 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication |
| F13.920 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated |
| F13.921 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium |
| F13.929 | Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified |
| F13.93 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal |
| F13.930 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated |
| F13.931 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium |
| F13.932 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances |
| F13.939 | Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified |
| F13.94 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.95 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder |
| F13.950 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.951 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.959 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.96 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder |
| F13.97 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia |
| F13.98 | Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders |
| F13.980 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.981 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.982 | Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.988 | Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.99 | Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F14.1 | Cocaine abuse |
| F14.10 | Cocaine abuse, uncomplicated |
| F14.11 | Cocaine abuse, in remission |
| F14.12 | Cocaine abuse with intoxication |
| F14.120 | Cocaine abuse with intoxication, uncomplicated |
| F14.121 | Cocaine abuse with intoxication with delirium |
| F14.122 | Cocaine abuse with intoxication with perceptual disturbance |
| F14.129 | Cocaine abuse with intoxication, unspecified |
| F14.13 | Cocaine abuse, unspecified with withdrawal |
| F14.14 | Cocaine abuse with cocaine-induced mood disorder |
| F14.15 | Cocaine abuse with cocaine-induced psychotic disorder |
| F14.150 | Cocaine abuse with cocaine-induced psychotic disorder with delusions |
| F14.151 | Cocaine abuse with cocaine-induced psychotic disorder with hallucinations |
| F14.159 | Cocaine abuse with cocaine-induced psychotic disorder, unspecified |
| F14.18 | Cocaine abuse with other cocaine-induced disorder |
| F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
| F14.181 | Cocaine abuse with cocaine-induced sexual dysfunction |
| F14.182 | Cocaine abuse with cocaine-induced sleep disorder |
| F14.188 | Cocaine abuse with other cocaine-induced disorder |
| F14.19 | Cocaine abuse with unspecified cocaine-induced disorder |
| F14.2 | Cocaine dependence |
| F14.20 | Cocaine dependence, uncomplicated |
| F14.21 | Cocaine dependence, in remission |
| F14.22 | Cocaine dependence with intoxication |
| F14.220 | Cocaine dependence with intoxication, uncomplicated |
| F14.221 | Cocaine dependence with intoxication delirium |
| F14.222 | Cocaine dependence with intoxication with perceptual disturbance |
| F14.229 | Cocaine dependence with intoxication, unspecified |
| F14.23 | Cocaine dependence with withdrawal |
| F14.24 | Cocaine dependence with cocaine-induced mood disorder |
| F14.25 | Cocaine dependence with cocaine-induced psychotic disorder |
| F14.250 | Cocaine dependence with cocaine-induced psychotic disorder with delusions |
| F14.251 | Cocaine dependence with cocaine-induced psychotic disorder with hallucinations |
| F14.259 | Cocaine dependence with cocaine-induced psychotic disorder, unspecified |
| F14.28 | Cocaine dependence with other cocaine-induced disorder |
| F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
| F14.281 | Cocaine dependence with cocaine-induced sexual dysfunction |
| F14.282 | Cocaine dependence with cocaine-induced sleep disorder |
| F14.288 | Cocaine dependence with other cocaine-induced disorder |
| F14.29 | Cocaine dependence with unspecified cocaine-induced disorder |
| F14.9 | Cocaine use, unspecified |
| F14.90 | Cocaine use, unspecified, uncomplicated |
| F14.92 | Cocaine use, unspecified with intoxication |
| F14.920 | Cocaine use, unspecified with intoxication, uncomplicated |
| F14.921 | Cocaine use, unspecified with intoxication delirium |
| F14.922 | Cocaine use, unspecified with intoxication with perceptual disturbance |
| F14.929 | Cocaine use, unspecified with intoxication, unspecified |
| F14.93 | Cocaine use, unspecified with withdrawal |
| F14.94 | Cocaine use, unspecified with cocaine-induced mood disorder |
| F14.95 | Cocaine use, unspecified with cocaine-induced psychotic disorder |
| F14.950 | Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions |
| F14.951 | Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations |
| F14.959 | Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified |
| F14.98 | Cocaine use, unspecified with other specified cocaine-induced disorder |
| F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
| F14.981 | Cocaine use, unspecified with cocaine-induced sexual dysfunction |
| F14.982 | Cocaine use, unspecified with cocaine-induced sleep disorder |
| F14.988 | Cocaine use, unspecified with other cocaine-induced disorder |
| F14.99 | Cocaine use, unspecified with unspecified cocaine-induced disorder |
| F15.1 | Other stimulant abuse |
| F15.10 | Other stimulant abuse, uncomplicated |
| F15.11 | Other stimulant abuse, in remission |
| F15.12 | Other stimulant abuse with intoxication |
| F15.120 | Other stimulant abuse with intoxication, uncomplicated |
| F15.121 | Other stimulant abuse with intoxication delirium |
| F15.122 | Other stimulant abuse with intoxication with perceptual disturbance |
| F15.129 | Other stimulant abuse with intoxication, unspecified |
| F15.13 | Other stimulant abuse with withdrawal |
| F15.14 | Other stimulant abuse with stimulant-induced mood disorder |
| F15.15 | Other stimulant abuse with stimulant-induced psychotic disorder |
| F15.150 | Other stimulant abuse with stimulant-induced psychotic disorder with delusions |
| F15.151 | Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations |
| F15.159 | Other stimulant abuse with stimulant-induced psychotic disorder, unspecified |
| F15.18 | Other stimulant abuse with other stimulant-induced disorder |
| F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
| F15.181 | Other stimulant abuse with stimulant-induced sexual dysfunction |
| F15.182 | Other stimulant abuse with stimulant-induced sleep disorder |
| F15.188 | Other stimulant abuse with other stimulant-induced disorder |
| F15.19 | Other stimulant abuse with unspecified stimulant-induced disorder |
| F15.2 | Other stimulant dependence |
| F15.20 | Other stimulant dependence, uncomplicated |
| F15.21 | Other stimulant dependence, in remission |
| F15.22 | Other stimulant dependence with intoxication |
| F15.220 | Other stimulant dependence with intoxication, uncomplicated |
| F15.221 | Other stimulant dependence with intoxication delirium |
| F15.222 | Other stimulant dependence with intoxication with perceptual disturbance |
| F15.229 | Other stimulant dependence with intoxication, unspecified |
| F15.23 | Other stimulant dependence with withdrawal |
| F15.24 | Other stimulant dependence with stimulant-induced mood disorder |
| F15.25 | Other stimulant dependence with stimulant-induced psychotic disorder |
| F15.250 | Other stimulant dependence with stimulant-induced psychotic disorder with delusions |
| F15.251 | Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations |
| F15.259 | Other stimulant dependence with stimulant-induced psychotic disorder, unspecified |
| F15.28 | Other stimulant dependence with other stimulant-induced disorder |
| F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
| F15.281 | Other stimulant dependence with stimulant-induced sexual dysfunction |
| F15.282 | Other stimulant dependence with stimulant-induced sleep disorder |
| F15.288 | Other stimulant dependence with other stimulant-induced disorder |
| F15.29 | Other stimulant dependence with unspecified stimulant-induced disorder |
| F15.9 | Other stimulant use, unspecified |
| F15.90 | Other stimulant use, unspecified, uncomplicated |
| F15.92 | Other stimulant use, unspecified with intoxication |
| F15.920 | Other stimulant use, unspecified with intoxication, uncomplicated |
| F15.921 | Other stimulant use, unspecified with intoxication delirium |
| F15.922 | Other stimulant use, unspecified with intoxication with perceptual disturbance |
| F15.929 | Other stimulant use, unspecified with intoxication, unspecified |
| F15.93 | Other stimulant use, unspecified with withdrawal |
| F15.94 | Other stimulant use, unspecified with stimulant-induced mood disorder |
| F15.95 | Other stimulant use, unspecified with stimulant-induced psychotic disorder |
| F15.950 | Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions |
| F15.951 | Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations |
| F15.959 | Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified |
| F15.98 | Other stimulant use, unspecified with other stimulant-induced disorder |
| F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
| F15.981 | Other stimulant use, unspecified with stimulant-induced sexual dysfunction |
| F15.982 | Other stimulant use, unspecified with stimulant-induced sleep disorder |
| F15.988 | Other stimulant use, unspecified with other stimulant-induced disorder |
| F15.99 | Other stimulant use, unspecified with unspecified stimulant-induced disorder |
| F16.1 | Hallucinogen abuse |
| F16.10 | Hallucinogen abuse, uncomplicated |
| F16.11 | Hallucinogen abuse, in remission |
| F16.12 | Hallucinogen abuse with intoxication |
| F16.120 | Hallucinogen abuse with intoxication, uncomplicated |
| F16.121 | Hallucinogen abuse with intoxication with delirium |
| F16.122 | Hallucinogen abuse with intoxication with perceptual disturbance |
| F16.129 | Hallucinogen abuse with intoxication, unspecified |
| F16.14 | Hallucinogen abuse with hallucinogen-induced mood disorder |
| F16.15 | Hallucinogen abuse with hallucinogen-induced psychotic disorder |
| F16.150 | Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions |
| F16.151 | Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations |
| F16.159 | Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified |
| F16.18 | Hallucinogen abuse with other hallucinogen-induced disorder |
| F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
| F16.183 | Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks) |
| F16.188 | Hallucinogen abuse with other hallucinogen-induced disorder |
| F16.19 | Hallucinogen abuse with unspecified hallucinogen-induced disorder |
| F16.2 | Hallucinogen dependence |
| F16.20 | Hallucinogen dependence, uncomplicated |
| F16.21 | Hallucinogen dependence, in remission |
| F16.22 | Hallucinogen dependence with intoxication |
| F16.220 | Hallucinogen dependence with intoxication, uncomplicated |
| F16.221 | Hallucinogen dependence with intoxication with delirium |
| F16.229 | Hallucinogen dependence with intoxication, unspecified |
| F16.24 | Hallucinogen dependence with hallucinogen-induced mood disorder |
| F16.25 | Hallucinogen dependence with hallucinogen-induced psychotic disorder |
| F16.250 | Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions |
| F16.251 | Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations |
| F16.259 | Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified |
| F16.28 | Hallucinogen dependence with other hallucinogen-induced disorder |
| F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
| F16.283 | Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks) |
| F16.288 | Hallucinogen dependence with other hallucinogen-induced disorder |
| F16.29 | Hallucinogen dependence with unspecified hallucinogen-induced disorder |
| F16.9 | Hallucinogen use, unspecified |
| F16.90 | Hallucinogen use, unspecified, uncomplicated |
| F16.92 | Hallucinogen use, unspecified with intoxication |
| F16.920 | Hallucinogen use, unspecified with intoxication, uncomplicated |
| F16.921 | Hallucinogen use, unspecified with intoxication with delirium |
| F16.929 | Hallucinogen use, unspecified with intoxication, unspecified |
| F16.94 | Hallucinogen use, unspecified with hallucinogen-induced mood disorder |
| F16.95 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder |
| F16.950 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions |
| F16.951 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations |
| F16.959 | Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified |
| F16.98 | Hallucinogen use, unspecified with other specified hallucinogen-induced disorder |
| F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
| F16.983 | Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks) |
| F16.988 | Hallucinogen use, unspecified with other hallucinogen-induced disorder |
| F16.99 | Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder |
| F18.1 | Inhalant abuse |
| F18.10 | Inhalant abuse, uncomplicated |
| F18.11 | Inhalant abuse, in remission |
| F18.12 | Inhalant abuse with intoxication |
| F18.120 | Inhalant abuse with intoxication, uncomplicated |
| F18.121 | Inhalant abuse with intoxication delirium |
| F18.129 | Inhalant abuse with intoxication, unspecified |
| F18.14 | Inhalant abuse with inhalant-induced mood disorder |
| F18.15 | Inhalant abuse with inhalant-induced psychotic disorder |
| F18.150 | Inhalant abuse with inhalant-induced psychotic disorder with delusions |
| F18.151 | Inhalant abuse with inhalant-induced psychotic disorder with hallucinations |
| F18.159 | Inhalant abuse with inhalant-induced psychotic disorder, unspecified |
| F18.17 | Inhalant abuse with inhalant-induced dementia |
| F18.18 | Inhalant abuse with other inhalant-induced disorders |
| F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
| F18.188 | Inhalant abuse with other inhalant-induced disorder |
| F18.19 | Inhalant abuse with unspecified inhalant-induced disorder |
| F18.2 | Inhalant dependence |
| F18.20 | Inhalant dependence, uncomplicated |
| F18.21 | Inhalant dependence, in remission |
| F18.22 | Inhalant dependence with intoxication |
| F18.220 | Inhalant dependence with intoxication, uncomplicated |
| F18.221 | Inhalant dependence with intoxication delirium |
| F18.229 | Inhalant dependence with intoxication, unspecified |
| F18.24 | Inhalant dependence with inhalant-induced mood disorder |
| F18.25 | Inhalant dependence with inhalant-induced psychotic disorder |
| F18.250 | Inhalant dependence with inhalant-induced psychotic disorder with delusions |
| F18.251 | Inhalant dependence with inhalant-induced psychotic disorder with hallucinations |
| F18.259 | Inhalant dependence with inhalant-induced psychotic disorder, unspecified |
| F18.27 | Inhalant dependence with inhalant-induced dementia |
| F18.28 | Inhalant dependence with other inhalant-induced disorders |
| F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
| F18.288 | Inhalant dependence with other inhalant-induced disorder |
| F18.29 | Inhalant dependence with unspecified inhalant-induced disorder |
| F18.9 | Inhalant use, unspecified |
| F18.90 | Inhalant use, unspecified, uncomplicated |
| F18.92 | Inhalant use, unspecified with intoxication |
| F18.920 | Inhalant use, unspecified with intoxication, uncomplicated |
| F18.921 | Inhalant use, unspecified with intoxication with delirium |
| F18.929 | Inhalant use, unspecified with intoxication, unspecified |
| F18.94 | Inhalant use, unspecified with inhalant-induced mood disorder |
| F18.95 | Inhalant use, unspecified with inhalant-induced psychotic disorder |
| F18.950 | Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions |
| F18.951 | Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations |
| F18.959 | Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified |
| F18.97 | Inhalant use, unspecified with inhalant-induced persisting dementia |
| F18.98 | Inhalant use, unspecified with other inhalant-induced disorders |
| F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
| F18.988 | Inhalant use, unspecified with other inhalant-induced disorder |
| F18.99 | Inhalant use, unspecified with unspecified inhalant-induced disorder |
| F19.1 | Other psychoactive substance abuse |
| F19.10 | Other psychoactive substance abuse, uncomplicated |
| F19.11 | Other psychoactive substance abuse, in remission |
| F19.12 | Other psychoactive substance abuse with intoxication |
| F19.120 | Other psychoactive substance abuse with intoxication, uncomplicated |
| F19.121 | Other psychoactive substance abuse with intoxication delirium |
| F19.122 | Other psychoactive substance abuse with intoxication with perceptual disturbances |
| F19.129 | Other psychoactive substance abuse with intoxication, unspecified |
| F19.13 | Other psychoactive substance abuse with withdrawal |
| F19.130 | Other psychoactive substance abuse with withdrawal, uncomplicated |
| F19.131 | Other psychoactive substance abuse with withdrawal delirium |
| F19.132 | Other psychoactive substance abuse with withdrawal with perceptual disturbance |
| F19.139 | Other psychoactive substance abuse with withdrawal, unspecified |
| F19.14 | Other psychoactive substance abuse with psychoactive substance-induced mood disorder |
| F19.15 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder |
| F19.150 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions |
| F19.151 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.159 | Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified |
| F19.16 | Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder |
| F19.17 | Other psychoactive substance abuse with psychoactive substance-induced persisting dementia |
| F19.18 | Other psychoactive substance abuse with other psychoactive substance-induced disorders |
| F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
| F19.181 | Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction |
| F19.182 | Other psychoactive substance abuse with psychoactive substance-induced sleep disorder |
| F19.188 | Other psychoactive substance abuse with other psychoactive substance-induced disorder |
| F19.19 | Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder |
| F19.2 | Other psychoactive substance dependence |
| F19.20 | Other psychoactive substance dependence, uncomplicated |
| F19.21 | Other psychoactive substance dependence, in remission |
| F19.22 | Other psychoactive substance dependence with intoxication |
| F19.220 | Other psychoactive substance dependence with intoxication, uncomplicated |
| F19.221 | Other psychoactive substance dependence with intoxication delirium |
| F19.222 | Other psychoactive substance dependence with intoxication with perceptual disturbance |
| F19.229 | Other psychoactive substance dependence with intoxication, unspecified |
| F19.23 | Other psychoactive substance dependence with withdrawal |
| F19.230 | Other psychoactive substance dependence with withdrawal, uncomplicated |
| F19.231 | Other psychoactive substance dependence with withdrawal delirium |
| F19.232 | Other psychoactive substance dependence with withdrawal with perceptual disturbance |
| F19.239 | Other psychoactive substance dependence with withdrawal, unspecified |
| F19.24 | Other psychoactive substance dependence with psychoactive substance-induced mood disorder |
| F19.25 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder |
| F19.250 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions |
| F19.251 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.259 | Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified |
| F19.26 | Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder |
| F19.27 | Other psychoactive substance dependence with psychoactive substance-induced persisting dementia |
| F19.28 | Other psychoactive substance dependence with other psychoactive substance-induced disorders |
| F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
| F19.281 | Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction |
| F19.282 | Other psychoactive substance dependence with psychoactive substance-induced sleep disorder |
| F19.288 | Other psychoactive substance dependence with other psychoactive substance-induced disorder |
| F19.29 | Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder |
| F19.9 | Other psychoactive substance use, unspecified |
| F19.90 | Other psychoactive substance use, unspecified, uncomplicated |
| F19.92 | Other psychoactive substance use, unspecified with intoxication |
| F19.920 | Other psychoactive substance use, unspecified with intoxication, uncomplicated |
| F19.921 | Other psychoactive substance use, unspecified with intoxication with delirium |
| F19.922 | Other psychoactive substance use, unspecified with intoxication with perceptual disturbance |
| F19.929 | Other psychoactive substance use, unspecified with intoxication, unspecified |
| F19.93 | Other psychoactive substance use, unspecified with withdrawal |
| F19.930 | Other psychoactive substance use, unspecified with withdrawal, uncomplicated |
| F19.931 | Other psychoactive substance use, unspecified with withdrawal delirium |
| F19.932 | Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance |
| F19.939 | Other psychoactive substance use, unspecified with withdrawal, unspecified |
| F19.94 | Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder |
| F19.95 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder |
| F19.950 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions |
| F19.951 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.959 | Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified |
| F19.96 | Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder |
| F19.97 | Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia |
| F19.98 | Other psychoactive substance use, unspecified with other psychoactive substance-induced disorders |
| F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
| F19.981 | Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction |
| F19.982 | Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder |
| F19.988 | Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder |
| F19.99 | Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder |
| F55.0 | Abuse of antacids |
| F55.1 | Abuse of herbal or folk remedies |
| F55.2 | Abuse of laxatives |
| F55.3 | Abuse of steroids or hormones |
| F55.4 | Abuse of vitamins |
| F55.8 | Abuse of other non-psychoactive substances |
| G58.0 | Intercostal neuropathy |
| G58.7 | Mononeuritis multiplex |
| G58.8 | Other specified mononeuropathies |
| G58.9 | Mononeuropathy, unspecified |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.1 | Refsum's disease |
| G60.2 | Neuropathy in association with hereditary ataxia |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G60.9 | Hereditary and idiopathic neuropathy, unspecified |
| G61.0 | Guillain-Barre syndrome |
| G61.1 | Serum neuropathy |
| G61.8 | Other inflammatory polyneuropathies |
| G61.81 | Chronic inflammatory demyelinating polyneuritis |
| G61.82 | Multifocal motor neuropathy |
| G61.89 | Other inflammatory polyneuropathies |
| G61.9 | Inflammatory polyneuropathy, unspecified |
| G62.0 | Drug-induced polyneuropathy |
| G62.1 | Alcoholic polyneuropathy |
| G62.2 | Polyneuropathy due to other toxic agents |
| G62.8 | Other specified polyneuropathies |
| G62.81 | Critical illness polyneuropathy |
| G62.82 | Radiation-induced polyneuropathy |
| G62.89 | Other specified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G89.29 | Other chronic pain |
| G89.4 | Chronic pain syndrome |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| G99.2 | Myelopathy in diseases classified elsewhere |
| G99.8 | Other specified disorders of nervous system in diseases classified elsewhere |
| H35.06 | Retinal vasculitis |
| H35.061 | Retinal vasculitis, right eye |
| H35.062 | Retinal vasculitis, left eye |
| H35.063 | Retinal vasculitis, bilateral |
| H35.069 | Retinal vasculitis, unspecified eye |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I67.7 | Cerebral arteritis, not elsewhere classified |
| I68.2 | Cerebral arteritis in other diseases classified elsewhere |
| I77.0 | Arteriovenous fistula, acquired |
| I77.1 | Stricture of artery |
| I77.2 | Rupture of artery |
| I77.3 | Arterial fibromuscular dysplasia |
| I77.4 | Celiac artery compression syndrome |
| I77.5 | Necrosis of artery |
| I77.6 | Arteritis, unspecified |
| I77.7 | Other arterial dissection |
| I77.70 | Dissection of unspecified artery |
| I77.71 | Dissection of carotid artery |
| I77.72 | Dissection of iliac artery |
| I77.73 | Dissection of renal artery |
| I77.74 | Dissection of vertebral artery |
| I77.75 | Dissection of other precerebral arteries |
| I77.76 | Dissection of artery of upper extremity |
| I77.77 | Dissection of artery of lower extremity |
| I77.79 | Dissection of other specified artery |
| I77.8 | Other specified disorders of arteries and arterioles |
| I77.81 | Aortic ectasia |
| I77.810 | Thoracic aortic ectasia |
| I77.811 | Abdominal aortic ectasia |
| I77.812 | Thoracoabdominal aortic ectasia |
| I77.819 | Aortic ectasia, unspecified site |
| I77.89 | Other specified disorders of arteries and arterioles |
| I77.9 | Disorder of arteries and arterioles, unspecified |
| K65.0 | Generalized (acute) peritonitis |
| K65.1 | Peritoneal abscess |
| K65.2 | Spontaneous bacterial peritonitis |
| K65.3 | Choleperitonitis |
| K65.4 | Sclerosing mesenteritis |
| K65.8 | Other peritonitis |
| K65.9 | Peritonitis, unspecified |
| K70.0 | Alcoholic fatty liver |
| K70.1 | Alcoholic hepatitis |
| K70.10 | Alcoholic hepatitis without ascites |
| K70.11 | Alcoholic hepatitis with ascites |
| K70.2 | Alcoholic fibrosis and sclerosis of liver |
| K70.3 | Alcoholic cirrhosis of liver |
| K70.30 | Alcoholic cirrhosis of liver without ascites |
| K70.31 | Alcoholic cirrhosis of liver with ascites |
| K70.4 | Alcoholic hepatic failure |
| K70.40 | Alcoholic hepatic failure without coma |
| K70.41 | Alcoholic hepatic failure with coma |
| K70.9 | Alcoholic liver disease, unspecified |
| K71.0 | Toxic liver disease with cholestasis |
| K71.1 | Toxic liver disease with hepatic necrosis |
| K71.10 | Toxic liver disease with hepatic necrosis, without coma |
| K71.11 | Toxic liver disease with hepatic necrosis, with coma |
| K71.2 | Toxic liver disease with acute hepatitis |
| K71.3 | Toxic liver disease with chronic persistent hepatitis |
| K71.4 | Toxic liver disease with chronic lobular hepatitis |
| K71.5 | Toxic liver disease with chronic active hepatitis |
| K71.50 | Toxic liver disease with chronic active hepatitis without ascites |
| K71.51 | Toxic liver disease with chronic active hepatitis with ascites |
| K71.6 | Toxic liver disease with hepatitis, not elsewhere classified |
| K71.7 | Toxic liver disease with fibrosis and cirrhosis of liver |
| K71.8 | Toxic liver disease with other disorders of liver |
| K71.9 | Toxic liver disease, unspecified |
| K72.0 | Acute and subacute hepatic failure |
| K72.00 | Acute and subacute hepatic failure without coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.1 | Chronic hepatic failure |
| K72.10 | Chronic hepatic failure without coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.9 | Hepatic failure, unspecified |
| K72.90 | Hepatic failure, unspecified without coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K73.0 | Chronic persistent hepatitis, not elsewhere classified |
| K73.1 | Chronic lobular hepatitis, not elsewhere classified |
| K73.2 | Chronic active hepatitis, not elsewhere classified |
| K73.8 | Other chronic hepatitis, not elsewhere classified |
| K73.9 | Chronic hepatitis, unspecified |
| K74.0 | Hepatic fibrosis |
| K74.00 | Hepatic fibrosis, unspecified |
| K74.01 | Hepatic fibrosis, early fibrosis |
| K74.02 | Hepatic fibrosis, advanced fibrosis |
| K74.1 | Hepatic sclerosis |
| K74.2 | Hepatic fibrosis with hepatic sclerosis |
| K74.3 | Primary biliary cirrhosis |
| K74.4 | Secondary biliary cirrhosis |
| K74.5 | Biliary cirrhosis, unspecified |
| K74.6 | Other and unspecified cirrhosis of liver |
| K74.60 | Unspecified cirrhosis of liver |
| K74.69 | Other cirrhosis of liver |
| K75.0 | Abscess of liver |
| K75.1 | Phlebitis of portal vein |
| K75.2 | Nonspecific reactive hepatitis |
| K75.3 | Granulomatous hepatitis, not elsewhere classified |
| K75.4 | Autoimmune hepatitis |
| K75.8 | Other specified inflammatory liver diseases |
| K75.81 | Nonalcoholic steatohepatitis (NASH) |
| K75.89 | Other specified inflammatory liver diseases |
| K75.9 | Inflammatory liver disease, unspecified |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K76.1 | Chronic passive congestion of liver |
| K76.2 | Central hemorrhagic necrosis of liver |
| K76.3 | Infarction of liver |
| K76.4 | Peliosis hepatis |
| K76.5 | Hepatic veno-occlusive disease |
| K76.6 | Portal hypertension |
| K76.7 | Hepatorenal syndrome |
| K76.8 | Other specified diseases of liver |
| K76.81 | Hepatopulmonary syndrome |
| K76.89 | Other specified diseases of liver |
| K76.9 | Liver disease, unspecified |
| L93.0 | Discoid lupus erythematosus |
| L93.1 | Subacute cutaneous lupus erythematosus |
| L93.2 | Other local lupus erythematosus |
| L95.0 | Livedoid vasculitis |
| L95.1 | Erythema elevatum diutinum |
| L95.8 | Other vasculitis limited to the skin |
| L95.9 | Vasculitis limited to the skin, unspecified |
| M05.2 | Rheumatoid vasculitis with rheumatoid arthritis |
| M05.20 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified site |
| M05.21 | Rheumatoid vasculitis with rheumatoid arthritis of shoulder |
| M05.211 | Rheumatoid vasculitis with rheumatoid arthritis of right shoulder |
| M05.212 | Rheumatoid vasculitis with rheumatoid arthritis of left shoulder |
| M05.219 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder |
| M05.22 | Rheumatoid vasculitis with rheumatoid arthritis of elbow |
| M05.221 | Rheumatoid vasculitis with rheumatoid arthritis of right elbow |
| M05.222 | Rheumatoid vasculitis with rheumatoid arthritis of left elbow |
| M05.229 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow |
| M05.23 | Rheumatoid vasculitis with rheumatoid arthritis of wrist |
| M05.231 | Rheumatoid vasculitis with rheumatoid arthritis of right wrist |
| M05.232 | Rheumatoid vasculitis with rheumatoid arthritis of left wrist |
| M05.239 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist |
| M05.24 | Rheumatoid vasculitis with rheumatoid arthritis of hand |
| M05.241 | Rheumatoid vasculitis with rheumatoid arthritis of right hand |
| M05.242 | Rheumatoid vasculitis with rheumatoid arthritis of left hand |
| M05.249 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand |
| M05.25 | Rheumatoid vasculitis with rheumatoid arthritis of hip |
| M05.251 | Rheumatoid vasculitis with rheumatoid arthritis of right hip |
| M05.252 | Rheumatoid vasculitis with rheumatoid arthritis of left hip |
| M05.259 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip |
| M05.26 | Rheumatoid vasculitis with rheumatoid arthritis of knee |
| M05.261 | Rheumatoid vasculitis with rheumatoid arthritis of right knee |
| M05.262 | Rheumatoid vasculitis with rheumatoid arthritis of left knee |
| M05.269 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee |
| M05.27 | Rheumatoid vasculitis with rheumatoid arthritis of ankle and foot |
| M05.271 | Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot |
| M05.272 | Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot |
| M05.279 | Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot |
| M05.29 | Rheumatoid vasculitis with rheumatoid arthritis of multiple sites |
| M05.50 | Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site |
| M25.5 | Pain in joint |
| M30.0 | Polyarteritis nodosa |
| M30.1 | Polyarteritis with lung involvement [Churg-Strauss] |
| M30.2 | Juvenile polyarteritis |
| M30.3 | Mucocutaneous lymph node syndrome [Kawasaki] |
| M30.8 | Other conditions related to polyarteritis nodosa |
| M31.0 | Hypersensitivity angiitis |
| M31.1 | Thrombotic microangiopathy |
| M31.2 | Lethal midline granuloma |
| M31.3 | Wegener's granulomatosis |
| M31.30 | Wegener's granulomatosis without renal involvement |
| M31.31 | Wegener's granulomatosis with renal involvement |
| M31.4 | Aortic arch syndrome [Takayasu] |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| M31.6 | Other giant cell arteritis |
| M31.7 | Microscopic polyangiitis |
| M31.8 | Other specified necrotizing vasculopathies |
| M31.9 | Necrotizing vasculopathy, unspecified |
| M32.0 | Drug-induced systemic lupus erythematosus |
| M32.1 | Systemic lupus erythematosus with organ or system involvement |
| M32.10 | Systemic lupus erythematosus, organ or system involvement unspecified |
| M32.11 | Endocarditis in systemic lupus erythematosus |
| M32.12 | Pericarditis in systemic lupus erythematosus |
| M32.13 | Lung involvement in systemic lupus erythematosus |
| M32.14 | Glomerular disease in systemic lupus erythematosus |
| M32.15 | Tubulo-interstitial nephropathy in systemic lupus erythematosus |
| M32.19 | Other organ or system involvement in systemic lupus erythematosus |
| M32.8 | Other forms of systemic lupus erythematosus |
| M32.9 | Systemic lupus erythematosus, unspecified |
| M34.83 | Systemic sclerosis with polyneuropathy |
| N00.0 | Acute nephritic syndrome with minor glomerular abnormality |
| N00.1 | Acute nephritic syndrome with focal and segmental glomerular lesions |
| N00.2 | Acute nephritic syndrome with diffuse membranous glomerulonephritis |
| N00.3 | Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N00.4 | Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N00.5 | Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N00.6 | Acute nephritic syndrome with dense deposit disease |
| N00.7 | Acute nephritic syndrome with diffuse crescentic glomerulonephritis |
| N00.8 | Acute nephritic syndrome with other morphologic changes |
| N00.9 | Acute nephritic syndrome with unspecified morphologic changes |
| N00.A | Acute nephritic syndrome with C3 glomerulonephritis |
| N02.0 | Recurrent and persistent hematuria with minor glomerular abnormality |
| N02.1 | Recurrent and persistent hematuria with focal and segmental glomerular lesions |
| N02.2 | Recurrent and persistent hematuria with diffuse membranous glomerulonephritis |
| N02.3 | Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis |
| N02.4 | Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis |
| N02.5 | Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis |
| N02.6 | Recurrent and persistent hematuria with dense deposit disease |
| N02.7 | Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis |
| N02.8 | Recurrent and persistent hematuria with other morphologic changes |
| N02.9 | Recurrent and persistent hematuria with unspecified morphologic changes |
| N02.A | Recurrent and persistent hematuria with C3 glomerulonephritis |
| N03.0 | Chronic nephritic syndrome with minor glomerular abnormality |
| N03.1 | Chronic nephritic syndrome with focal and segmental glomerular lesions |
| N03.2 | Chronic nephritic syndrome with diffuse membranous glomerulonephritis |
| N03.3 | Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N03.4 | Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N03.5 | Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N03.6 | Chronic nephritic syndrome with dense deposit disease |
| N03.7 | Chronic nephritic syndrome with diffuse crescentic glomerulonephritis |
| N03.8 | Chronic nephritic syndrome with other morphologic changes |
| N03.9 | Chronic nephritic syndrome with unspecified morphologic changes |
| N03.A | Chronic nephritic syndrome with C3 glomerulonephritis |
| N04.0 | Nephrotic syndrome with minor glomerular abnormality |
| N04.1 | Nephrotic syndrome with focal and segmental glomerular lesions |
| N04.2 | Nephrotic syndrome with diffuse membranous glomerulonephritis |
| N04.3 | Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N04.4 | Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N04.5 | Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N04.6 | Nephrotic syndrome with dense deposit disease |
| N04.7 | Nephrotic syndrome with diffuse crescentic glomerulonephritis |
| N04.8 | Nephrotic syndrome with other morphologic changes |
| N04.9 | Nephrotic syndrome with unspecified morphologic changes |
| N04.A | Nephrotic syndrome with C3 glomerulonephritis |
| N05.0 | Unspecified nephritic syndrome with minor glomerular abnormality |
| N05.1 | Unspecified nephritic syndrome with focal and segmental glomerular lesions |
| N05.2 | Unspecified nephritic syndrome with diffuse membranous glomerulonephritis |
| N05.3 | Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N05.4 | Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N05.5 | Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N05.6 | Unspecified nephritic syndrome with dense deposit disease |
| N05.7 | Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis |
| N05.8 | Unspecified nephritic syndrome with other morphologic changes |
| N05.9 | Unspecified nephritic syndrome with unspecified morphologic changes |
| N05.A | Unspecified nephritic syndrome with C3 glomerulonephritis |
| N06.0 | Isolated proteinuria with minor glomerular abnormality |
| N06.1 | Isolated proteinuria with focal and segmental glomerular lesions |
| N06.2 | Isolated proteinuria with diffuse membranous glomerulonephritis |
| N06.3 | Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis |
| N06.4 | Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis |
| N06.5 | Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis |
| N06.6 | Isolated proteinuria with dense deposit disease |
| N06.7 | Isolated proteinuria with diffuse crescentic glomerulonephritis |
| N06.8 | Isolated proteinuria with other morphologic lesion |
| N06.9 | Isolated proteinuria with unspecified morphologic lesion |
| N06.A | Isolated proteinuria with C3 glomerulonephritis |
| N13.0 | Hydronephrosis with ureteropelvic junction obstruction |
| N13.1 | Hydronephrosis with ureteral stricture, not elsewhere classified |
| N13.2 | Hydronephrosis with renal and ureteral calculous obstruction |
| N13.3 | Other and unspecified hydronephrosis |
| N13.30 | Unspecified hydronephrosis |
| N13.39 | Other hydronephrosis |
| N13.4 | Hydroureter |
| N13.5 | Crossing vessel and stricture of ureter without hydronephrosis |
| N13.6 | Pyonephrosis |
| N13.7 | Vesicoureteral-reflux |
| N13.70 | Vesicoureteral-reflux, unspecified |
| N13.71 | Vesicoureteral-reflux without reflux nephropathy |
| N13.72 | Vesicoureteral-reflux with reflux nephropathy without hydroureter |
| N13.721 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, unilateral |
| N13.722 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, bilateral |
| N13.729 | Vesicoureteral-reflux with reflux nephropathy without hydroureter, unspecified |
| N13.73 | Vesicoureteral-reflux with reflux nephropathy with hydroureter |
| N13.731 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, unilateral |
| N13.732 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, bilateral |
| N13.739 | Vesicoureteral-reflux with reflux nephropathy with hydroureter, unspecified |
| N13.8 | Other obstructive and reflux uropathy |
| N13.9 | Obstructive and reflux uropathy, unspecified |
| N18.1 | Chronic kidney disease, stage 1 |
| N18.2 | Chronic kidney disease, stage 2 (mild) |
| N18.3 | Chronic kidney disease, stage 3 (moderate) |
| N18.30 | Chronic kidney disease, stage 3 unspecified |
| N18.31 | Chronic kidney disease, stage 3a |
| N18.32 | Chronic kidney disease, stage 3b |
| N18.4 | Chronic kidney disease, stage 4 (severe) |
| N18.5 | Chronic kidney disease, stage 5 |
| N18.6 | End stage renal disease |
| N18.9 | Chronic kidney disease, unspecified |
| N26.1 | Atrophy of kidney (terminal) |
| N26.2 | Page kidney |
| N26.9 | Renal sclerosis, unspecified |
| N98.3 | Complications of attempted introduction of embryo in embryo transfer |
| O09.0 | Supervision of pregnancy with history of infertility |
| O09.00 | Supervision of pregnancy with history of infertility, unspecified trimester |
| O09.01 | Supervision of pregnancy with history of infertility, first trimester |
| O09.02 | Supervision of pregnancy with history of infertility, second trimester |
| O09.03 | Supervision of pregnancy with history of infertility, third trimester |
| O09.1 | Supervision of pregnancy with history of ectopic pregnancy |
| O09.10 | Supervision of pregnancy with history of ectopic pregnancy, unspecified trimester |
| O09.11 | Supervision of pregnancy with history of ectopic pregnancy, first trimester |
| O09.12 | Supervision of pregnancy with history of ectopic pregnancy, second trimester |
| O09.13 | Supervision of pregnancy with history of ectopic pregnancy, third trimester |
| O09.2 | Supervision of pregnancy with other poor reproductive or obstetric history |
| O09.21 | Supervision of pregnancy with history of pre-term labor |
| O09.211 | Supervision of pregnancy with history of pre-term labor, first trimester |
| O09.212 | Supervision of pregnancy with history of pre-term labor, second trimester |
| O09.213 | Supervision of pregnancy with history of pre-term labor, third trimester |
| O09.219 | Supervision of pregnancy with history of pre-term labor, unspecified trimester |
| O09.29 | Supervision of pregnancy with other poor reproductive or obstetric history |
| O09.291 | Supervision of pregnancy with other poor reproductive or obstetric history, first trimester |
| O09.292 | Supervision of pregnancy with other poor reproductive or obstetric history, second trimester |
| O09.293 | Supervision of pregnancy with other poor reproductive or obstetric history, third trimester |
| O09.299 | Supervision of pregnancy with other poor reproductive or obstetric history, unspecified trimester |
| O09.3 | Supervision of pregnancy with insufficient antenatal care |
| O09.30 | Supervision of pregnancy with insufficient antenatal care, unspecified trimester |
| O09.31 | Supervision of pregnancy with insufficient antenatal care, first trimester |
| O09.32 | Supervision of pregnancy with insufficient antenatal care, second trimester |
| O09.33 | Supervision of pregnancy with insufficient antenatal care, third trimester |
| O09.4 | Supervision of pregnancy with grand multiparity |
| O09.40 | Supervision of pregnancy with grand multiparity, unspecified trimester |
| O09.41 | Supervision of pregnancy with grand multiparity, first trimester |
| O09.42 | Supervision of pregnancy with grand multiparity, second trimester |
| O09.43 | Supervision of pregnancy with grand multiparity, third trimester |
| O09.5 | Supervision of elderly primigravida and multigravida |
| O09.51 | Supervision of elderly primigravida |
| O09.511 | Supervision of elderly primigravida, first trimester |
| O09.512 | Supervision of elderly primigravida, second trimester |
| O09.513 | Supervision of elderly primigravida, third trimester |
| O09.519 | Supervision of elderly primigravida, unspecified trimester |
| O09.52 | Supervision of elderly multigravida |
| O09.521 | Supervision of elderly multigravida, first trimester |
| O09.522 | Supervision of elderly multigravida, second trimester |
| O09.523 | Supervision of elderly multigravida, third trimester |
| O09.529 | Supervision of elderly multigravida, unspecified trimester |
| O09.6 | Supervision of young primigravida and multigravida |
| O09.61 | Supervision of young primigravida |
| O09.611 | Supervision of young primigravida, first trimester |
| O09.612 | Supervision of young primigravida, second trimester |
| O09.613 | Supervision of young primigravida, third trimester |
| O09.619 | Supervision of young primigravida, unspecified trimester |
| O09.62 | Supervision of young multigravida |
| O09.621 | Supervision of young multigravida, first trimester |
| O09.622 | Supervision of young multigravida, second trimester |
| O09.623 | Supervision of young multigravida, third trimester |
| O09.629 | Supervision of young multigravida, unspecified trimester |
| O09.7 | Supervision of high risk pregnancy due to social problems |
| O09.70 | Supervision of high risk pregnancy due to social problems, unspecified trimester |
| O09.71 | Supervision of high risk pregnancy due to social problems, first trimester |
| O09.72 | Supervision of high risk pregnancy due to social problems, second trimester |
| O09.73 | Supervision of high risk pregnancy due to social problems, third trimester |
| O09.8 | Supervision of other high risk pregnancies |
| O09.81 | Supervision of pregnancy resulting from assisted reproductive technology |
| O09.811 | Supervision of pregnancy resulting from assisted reproductive technology, first trimester |
| O09.812 | Supervision of pregnancy resulting from assisted reproductive technology, second trimester |
| O09.813 | Supervision of pregnancy resulting from assisted reproductive technology, third trimester |
| O09.819 | Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimester |
| O09.82 | Supervision of pregnancy with history of in utero procedure during previous pregnancy |
| O09.821 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimester |
| O09.822 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimester |
| O09.823 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimester |
| O09.829 | Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimester |
| O09.89 | Supervision of other high risk pregnancies |
| O09.891 | Supervision of other high risk pregnancies, first trimester |
| O09.892 | Supervision of other high risk pregnancies, second trimester |
| O09.893 | Supervision of other high risk pregnancies, third trimester |
| O09.899 | Supervision of other high risk pregnancies, unspecified trimester |
| O09.9 | Supervision of high risk pregnancy, unspecified |
| O09.90 | Supervision of high risk pregnancy, unspecified, unspecified trimester |
| O09.91 | Supervision of high risk pregnancy, unspecified, first trimester |
| O09.92 | Supervision of high risk pregnancy, unspecified, second trimester |
| O09.93 | Supervision of high risk pregnancy, unspecified, third trimester |
| O09.A | Supervision of pregnancy with history of molar pregnancy |
| O09.A0 | Supervision of pregnancy with history of molar pregnancy, unspecified trimester |
| O09.A1 | Supervision of pregnancy with history of molar pregnancy, first trimester |
| O09.A2 | Supervision of pregnancy with history of molar pregnancy, second trimester |
| O09.A3 | Supervision of pregnancy with history of molar pregnancy, third trimester |
| O12.0 | Gestational edema |
| O12.00 | Gestational edema, unspecified trimester |
| O12.01 | Gestational edema, first trimester |
| O12.02 | Gestational edema, second trimester |
| O12.03 | Gestational edema, third trimester |
| O12.04 | Gestational edema, complicating childbirth |
| O12.05 | Gestational edema, complicating the puerperium |
| O12.1 | Gestational proteinuria |
| O12.10 | Gestational proteinuria, unspecified trimester |
| O12.11 | Gestational proteinuria, first trimester |
| O12.12 | Gestational proteinuria, second trimester |
| O12.13 | Gestational proteinuria, third trimester |
| O12.14 | Gestational proteinuria, complicating childbirth |
| O12.15 | Gestational proteinuria, complicating the puerperium |
| O12.2 | Gestational edema with proteinuria |
| O12.20 | Gestational edema with proteinuria, unspecified trimester |
| O12.21 | Gestational edema with proteinuria, first trimester |
| O12.22 | Gestational edema with proteinuria, second trimester |
| O12.23 | Gestational edema with proteinuria, third trimester |
| O12.24 | Gestational edema with proteinuria, complicating childbirth |
| O12.25 | Gestational edema with proteinuria, complicating the puerperium |
| O26.0 | Excessive weight gain in pregnancy |
| O26.00 | Excessive weight gain in pregnancy, unspecified trimester |
| O26.01 | Excessive weight gain in pregnancy, first trimester |
| O26.02 | Excessive weight gain in pregnancy, second trimester |
| O26.03 | Excessive weight gain in pregnancy, third trimester |
| O26.1 | Low weight gain in pregnancy |
| O26.10 | Low weight gain in pregnancy, unspecified trimester |
| O26.11 | Low weight gain in pregnancy, first trimester |
| O26.12 | Low weight gain in pregnancy, second trimester |
| O26.13 | Low weight gain in pregnancy, third trimester |
| O26.2 | Pregnancy care for patient with recurrent pregnancy loss |
| O26.20 | Pregnancy care for patient with recurrent pregnancy loss, unspecified trimester |
| O26.21 | Pregnancy care for patient with recurrent pregnancy loss, first trimester |
| O26.22 | Pregnancy care for patient with recurrent pregnancy loss, second trimester |
| O26.23 | Pregnancy care for patient with recurrent pregnancy loss, third trimester |
| O26.3 | Retained intrauterine contraceptive device in pregnancy |
| O26.30 | Retained intrauterine contraceptive device in pregnancy, unspecified trimester |
| O26.31 | Retained intrauterine contraceptive device in pregnancy, first trimester |
| O26.32 | Retained intrauterine contraceptive device in pregnancy, second trimester |
| O26.33 | Retained intrauterine contraceptive device in pregnancy, third trimester |
| O26.4 | Herpes gestationis |
| O26.40 | Herpes gestationis, unspecified trimester |
| O26.41 | Herpes gestationis, first trimester |
| O26.42 | Herpes gestationis, second trimester |
| O26.43 | Herpes gestationis, third trimester |
| O26.5 | Maternal hypotension syndrome |
| O26.50 | Maternal hypotension syndrome, unspecified trimester |
| O26.51 | Maternal hypotension syndrome, first trimester |
| O26.52 | Maternal hypotension syndrome, second trimester |
| O26.53 | Maternal hypotension syndrome, third trimester |
| O26.6 | Liver and biliary tract disorders in pregnancy, childbirth and the puerperium |
| O26.61 | Liver and biliary tract disorders in pregnancy |
| O26.611 | Liver and biliary tract disorders in pregnancy, first trimester |
| O26.612 | Liver and biliary tract disorders in pregnancy, second trimester |
| O26.613 | Liver and biliary tract disorders in pregnancy, third trimester |
| O26.619 | Liver and biliary tract disorders in pregnancy, unspecified trimester |
| O26.62 | Liver and biliary tract disorders in childbirth |
| O26.63 | Liver and biliary tract disorders in the puerperium |
| O26.7 | Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium |
| O26.71 | Subluxation of symphysis (pubis) in pregnancy |
| O26.711 | Subluxation of symphysis (pubis) in pregnancy, first trimester |
| O26.712 | Subluxation of symphysis (pubis) in pregnancy, second trimester |
| O26.713 | Subluxation of symphysis (pubis) in pregnancy, third trimester |
| O26.719 | Subluxation of symphysis (pubis) in pregnancy, unspecified trimester |
| O26.72 | Subluxation of symphysis (pubis) in childbirth |
| O26.73 | Subluxation of symphysis (pubis) in the puerperium |
| O26.8 | Other specified pregnancy related conditions |
| O26.81 | Pregnancy related exhaustion and fatigue |
| O26.811 | Pregnancy related exhaustion and fatigue, first trimester |
| O26.812 | Pregnancy related exhaustion and fatigue, second trimester |
| O26.813 | Pregnancy related exhaustion and fatigue, third trimester |
| O26.819 | Pregnancy related exhaustion and fatigue, unspecified trimester |
| O26.82 | Pregnancy related peripheral neuritis |
| O26.821 | Pregnancy related peripheral neuritis, first trimester |
| O26.822 | Pregnancy related peripheral neuritis, second trimester |
| O26.823 | Pregnancy related peripheral neuritis, third trimester |
| O26.829 | Pregnancy related peripheral neuritis, unspecified trimester |
| O26.83 | Pregnancy related renal disease |
| O26.831 | Pregnancy related renal disease, first trimester |
| O26.832 | Pregnancy related renal disease, second trimester |
| O26.833 | Pregnancy related renal disease, third trimester |
| O26.839 | Pregnancy related renal disease, unspecified trimester |
| O26.84 | Uterine size-date discrepancy complicating pregnancy |
| O26.841 | Uterine size-date discrepancy, first trimester |
| O26.842 | Uterine size-date discrepancy, second trimester |
| O26.843 | Uterine size-date discrepancy, third trimester |
| O26.849 | Uterine size-date discrepancy, unspecified trimester |
| O26.85 | Spotting complicating pregnancy |
| O26.851 | Spotting complicating pregnancy, first trimester |
| O26.852 | Spotting complicating pregnancy, second trimester |
| O26.853 | Spotting complicating pregnancy, third trimester |
| O26.859 | Spotting complicating pregnancy, unspecified trimester |
| O26.86 | Pruritic urticarial papules and plaques of pregnancy (PUPPP) |
| O26.87 | Cervical shortening |
| O26.872 | Cervical shortening, second trimester |
| O26.873 | Cervical shortening, third trimester |
| O26.879 | Cervical shortening, unspecified trimester |
| O26.89 | Other specified pregnancy related conditions |
| O26.891 | Other specified pregnancy related conditions, first trimester |
| O26.892 | Other specified pregnancy related conditions, second trimester |
| O26.893 | Other specified pregnancy related conditions, third trimester |
| O26.899 | Other specified pregnancy related conditions, unspecified trimester |
| O26.9 | Pregnancy related conditions, unspecified |
| O26.90 | Pregnancy related conditions, unspecified, unspecified trimester |
| O26.91 | Pregnancy related conditions, unspecified, first trimester |
| O26.92 | Pregnancy related conditions, unspecified, second trimester |
| O26.93 | Pregnancy related conditions, unspecified, third trimester |
| O28.0 | Abnormal hematological finding on antenatal screening of mother |
| O28.1 | Abnormal biochemical finding on antenatal screening of mother |
| O28.2 | Abnormal cytological finding on antenatal screening of mother |
| O28.3 | Abnormal ultrasonic finding on antenatal screening of mother |
| O28.4 | Abnormal radiological finding on antenatal screening of mother |
| O28.5 | Abnormal chromosomal and genetic finding on antenatal screening of mother |
| O28.8 | Other abnormal findings on antenatal screening of mother |
| O28.9 | Unspecified abnormal findings on antenatal screening of mother |
| O98.4 | Viral hepatitis complicating pregnancy, childbirth and the puerperium |
| O98.41 | Viral hepatitis complicating pregnancy |
| O98.411 | Viral hepatitis complicating pregnancy, first trimester |
| O98.412 | Viral hepatitis complicating pregnancy, second trimester |
| O98.413 | Viral hepatitis complicating pregnancy, third trimester |
| O98.419 | Viral hepatitis complicating pregnancy, unspecified trimester |
| O98.42 | Viral hepatitis complicating childbirth |
| O98.43 | Viral hepatitis complicating the puerperium |
| P35.3 | Congenital viral hepatitis |
| P58.0 | Neonatal jaundice due to bruising |
| P58.1 | Neonatal jaundice due to bleeding |
| P58.2 | Neonatal jaundice due to infection |
| P58.3 | Neonatal jaundice due to polycythemia |
| P58.4 | Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn |
| P58.41 | Neonatal jaundice due to drugs or toxins transmitted from mother |
| P58.42 | Neonatal jaundice due to drugs or toxins given to newborn |
| P58.5 | Neonatal jaundice due to swallowed maternal blood |
| P58.8 | Neonatal jaundice due to other specified excessive hemolysis |
| P58.9 | Neonatal jaundice due to excessive hemolysis, unspecified |
| P59.0 | Neonatal jaundice associated with preterm delivery |
| P59.1 | Inspissated bile syndrome |
| P59.2 | Neonatal jaundice from other and unspecified hepatocellular damage |
| P59.20 | Neonatal jaundice from unspecified hepatocellular damage |
| P59.29 | Neonatal jaundice from other hepatocellular damage |
| P59.3 | Neonatal jaundice from breast milk inhibitor |
| P59.8 | Neonatal jaundice from other specified causes |
| P59.9 | Neonatal jaundice, unspecified |
| R16.0 | Hepatomegaly, not elsewhere classified |
| R16.1 | Splenomegaly, not elsewhere classified |
| R16.2 | Hepatomegaly with splenomegaly, not elsewhere classified |
| R18.0 | Malignant ascites |
| R18.8 | Other ascites |
| R19.0 | Intra-abdominal and pelvic swelling, mass and lump |
| R19.00 | Intra-abdominal and pelvic swelling, mass and lump, unspecified site |
| R19.01 | Right upper quadrant abdominal swelling, mass and lump |
| R19.02 | Left upper quadrant abdominal swelling, mass and lump |
| R19.03 | Right lower quadrant abdominal swelling, mass and lump |
| R19.04 | Left lower quadrant abdominal swelling, mass and lump |
| R19.05 | Periumbilic swelling, mass or lump |
| R19.06 | Epigastric swelling, mass or lump |
| R19.07 | Generalized intra-abdominal and pelvic swelling, mass and lump |
| R19.09 | Other intra-abdominal and pelvic swelling, mass and lump |
| R19.1 | Abnormal bowel sounds |
| R19.11 | Absent bowel sounds |
| R19.12 | Hyperactive bowel sounds |
| R19.15 | Other abnormal bowel sounds |
| R19.2 | Visible peristalsis |
| R19.3 | Abdominal rigidity |
| R19.30 | Abdominal rigidity, unspecified site |
| R19.31 | Right upper quadrant abdominal rigidity |
| R19.32 | Left upper quadrant abdominal rigidity |
| R19.33 | Right lower quadrant abdominal rigidity |
| R19.34 | Left lower quadrant abdominal rigidity |
| R19.35 | Periumbilic abdominal rigidity |
| R19.36 | Epigastric abdominal rigidity |
| R19.37 | Generalized abdominal rigidity |
| R19.4 | Change in bowel habit |
| R19.5 | Other fecal abnormalities |
| R19.6 | Halitosis |
| R19.7 | Diarrhea, unspecified |
| R19.8 | Other specified symptoms and signs involving the digestive system and abdomen |
| R77.0 | Abnormality of albumin |
| R77.1 | Abnormality of globulin |
| R77.2 | Abnormality of alphafetoprotein |
| R77.8 | Other specified abnormalities of plasma proteins |
| R77.9 | Abnormality of plasma protein, unspecified |
| R78.0 | Finding of alcohol in blood |
| R78.1 | Finding of opiate drug in blood |
| R78.2 | Finding of cocaine in blood |
| R78.3 | Finding of hallucinogen in blood |
| R78.4 | Finding of other drugs of addictive potential in blood |
| R78.5 | Finding of other psychotropic drug in blood |
| R78.6 | Finding of steroid agent in blood |
| R78.7 | Finding of abnormal level of heavy metals in blood |
| R78.71 | Abnormal lead level in blood |
| R78.79 | Finding of abnormal level of heavy metals in blood |
| R78.8 | Finding of other specified substances, not normally found in blood |
| R78.81 | Bacteremia |
| R78.89 | Finding of other specified substances, not normally found in blood |
| R78.9 | Finding of unspecified substance, not normally found in blood |
| R80.0 | Isolated proteinuria |
| R80.1 | Persistent proteinuria, unspecified |
| R80.2 | Orthostatic proteinuria, unspecified |
| R80.3 | Bence Jones proteinuria |
| R80.8 | Other proteinuria |
| R80.9 | Proteinuria, unspecified |
| R94.0 | Abnormal results of function studies of central nervous system |
| R94.01 | Abnormal electroencephalogram [EEG] |
| R94.02 | Abnormal brain scan |
| R94.09 | Abnormal results of other function studies of central nervous system |
| R94.1 | Abnormal results of function studies of peripheral nervous system and special senses |
| R94.11 | Abnormal results of function studies of eye |
| R94.110 | Abnormal electro-oculogram [EOG] |
| R94.111 | Abnormal electroretinogram [ERG] |
| R94.112 | Abnormal visually evoked potential [VEP] |
| R94.113 | Abnormal oculomotor study |
| R94.118 | Abnormal results of other function studies of eye |
| R94.12 | Abnormal results of function studies of ear and other special senses |
| R94.120 | Abnormal auditory function study |
| R94.121 | Abnormal vestibular function study |
| R94.128 | Abnormal results of other function studies of ear and other special senses |
| R94.13 | Abnormal results of function studies of peripheral nervous system |
| R94.130 | Abnormal response to nerve stimulation, unspecified |
| R94.131 | Abnormal electromyogram [EMG] |
| R94.138 | Abnormal results of other function studies of peripheral nervous system |
| R94.2 | Abnormal results of pulmonary function studies |
| R94.3 | Abnormal results of cardiovascular function studies |
| R94.30 | Abnormal result of cardiovascular function study, unspecified |
| R94.31 | Abnormal electrocardiogram [ECG] [EKG] |
| R94.39 | Abnormal result of other cardiovascular function study |
| R94.4 | Abnormal results of kidney function studies |
| R94.5 | Abnormal results of liver function studies |
| R94.6 | Abnormal results of thyroid function studies |
| R94.7 | Abnormal results of other endocrine function studies |
| R94.8 | Abnormal results of function studies of other organs and systems |
| T39.0 | Poisoning by, adverse effect of and underdosing of salicylates |
| T39.01 | Poisoning by, adverse effect of and underdosing of aspirin |
| T39.011 | Poisoning by aspirin, accidental (unintentional) |
| T39.011A | Poisoning by aspirin, accidental (unintentional), initial encounter |
| T39.011D | Poisoning by aspirin, accidental (unintentional), subsequent encounter |
| T39.011S | Poisoning by aspirin, accidental (unintentional), sequela |
| T39.012 | Poisoning by aspirin, intentional self-harm |
| T39.012A | Poisoning by aspirin, intentional self-harm, initial encounter |
| T39.012D | Poisoning by aspirin, intentional self-harm, subsequent encounter |
| T39.012S | Poisoning by aspirin, intentional self-harm, sequela |
| T39.013 | Poisoning by aspirin, assault |
| T39.013A | Poisoning by aspirin, assault, initial encounter |
| T39.013D | Poisoning by aspirin, assault, subsequent encounter |
| T39.013S | Poisoning by aspirin, assault, sequela |
| T39.014 | Poisoning by aspirin, undetermined |
| T39.014A | Poisoning by aspirin, undetermined, initial encounter |
| T39.014D | Poisoning by aspirin, undetermined, subsequent encounter |
| T39.014S | Poisoning by aspirin, undetermined, sequela |
| T39.015 | Adverse effect of aspirin |
| T39.015A | Adverse effect of aspirin, initial encounter |
| T39.015D | Adverse effect of aspirin, subsequent encounter |
| T39.015S | Adverse effect of aspirin, sequela |
| T39.016 | Underdosing of aspirin |
| T39.016A | Underdosing of aspirin, initial encounter |
| T39.016D | Underdosing of aspirin, subsequent encounter |
| T39.016S | Underdosing of aspirin, sequela |
| T39.09 | Poisoning by, adverse effect of and underdosing of other salicylates |
| T39.091 | Poisoning by salicylates, accidental (unintentional) |
| T39.091A | Poisoning by salicylates, accidental (unintentional), initial encounter |
| T39.091D | Poisoning by salicylates, accidental (unintentional), subsequent encounter |
| T39.091S | Poisoning by salicylates, accidental (unintentional), sequela |
| T39.092 | Poisoning by salicylates, intentional self-harm |
| T39.092A | Poisoning by salicylates, intentional self-harm, initial encounter |
| T39.092D | Poisoning by salicylates, intentional self-harm, subsequent encounter |
| T39.092S | Poisoning by salicylates, intentional self-harm, sequela |
| T39.093 | Poisoning by salicylates, assault |
| T39.093A | Poisoning by salicylates, assault, initial encounter |
| T39.093D | Poisoning by salicylates, assault, subsequent encounter |
| T39.093S | Poisoning by salicylates, assault, sequela |
| T39.094 | Poisoning by salicylates, undetermined |
| T39.094A | Poisoning by salicylates, undetermined, initial encounter |
| T39.094D | Poisoning by salicylates, undetermined, subsequent encounter |
| T39.094S | Poisoning by salicylates, undetermined, sequela |
| T39.095 | Adverse effect of salicylates |
| T39.095A | Adverse effect of salicylates, initial encounter |
| T39.095D | Adverse effect of salicylates, subsequent encounter |
| T39.095S | Adverse effect of salicylates, sequela |
| T39.096 | Underdosing of salicylates |
| T39.096A | Underdosing of salicylates, initial encounter |
| T39.096D | Underdosing of salicylates, subsequent encounter |
| T39.096S | Underdosing of salicylates, sequela |
| T39.1 | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X1 | Poisoning by 4-Aminophenol derivatives, accidental (unintentional) |
| T39.1X1A | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter |
| T39.1X1D | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter |
| T39.1X1S | Poisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela |
| T39.1X2 | Poisoning by 4-Aminophenol derivatives, intentional self-harm |
| T39.1X2A | Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter |
| T39.1X2D | Poisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter |
| T39.1X2S | Poisoning by 4-Aminophenol derivatives, intentional self-harm, sequela |
| T39.1X3 | Poisoning by 4-Aminophenol derivatives, assault |
| T39.1X3A | Poisoning by 4-Aminophenol derivatives, assault, initial encounter |
| T39.1X3D | Poisoning by 4-Aminophenol derivatives, assault, subsequent encounter |
| T39.1X3S | Poisoning by 4-Aminophenol derivatives, assault, sequela |
| T39.1X4 | Poisoning by 4-Aminophenol derivatives, undetermined |
| T39.1X4A | Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter |
| T39.1X4D | Poisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter |
| T39.1X4S | Poisoning by 4-Aminophenol derivatives, undetermined, sequela |
| T39.1X5 | Adverse effect of 4-Aminophenol derivatives |
| T39.1X5A | Adverse effect of 4-Aminophenol derivatives, initial encounter |
| T39.1X5D | Adverse effect of 4-Aminophenol derivatives, subsequent encounter |
| T39.1X5S | Adverse effect of 4-Aminophenol derivatives, sequela |
| T39.1X6 | Underdosing of 4-Aminophenol derivatives |
| T39.1X6A | Underdosing of 4-Aminophenol derivatives, initial encounter |
| T39.1X6D | Underdosing of 4-Aminophenol derivatives, subsequent encounter |
| T39.1X6S | Underdosing of 4-Aminophenol derivatives, sequela |
| T39.2 | Poisoning by, adverse effect of and underdosing of pyrazolone derivatives |
| T39.2X | Poisoning by, adverse effect of and underdosing of pyrazolone derivatives |
| T39.2X1 | Poisoning by pyrazolone derivatives, accidental (unintentional) |
| T39.2X1A | Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter |
| T39.2X1D | Poisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter |
| T39.2X1S | Poisoning by pyrazolone derivatives, accidental (unintentional), sequela |
| T39.2X2 | Poisoning by pyrazolone derivatives, intentional self-harm |
| T39.2X2A | Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter |
| T39.2X2D | Poisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter |
| T39.2X2S | Poisoning by pyrazolone derivatives, intentional self-harm, sequela |
| T39.2X3 | Poisoning by pyrazolone derivatives, assault |
| T39.2X3A | Poisoning by pyrazolone derivatives, assault, initial encounter |
| T39.2X3D | Poisoning by pyrazolone derivatives, assault, subsequent encounter |
| T39.2X3S | Poisoning by pyrazolone derivatives, assault, sequela |
| T39.2X4 | Poisoning by pyrazolone derivatives, undetermined |
| T39.2X4A | Poisoning by pyrazolone derivatives, undetermined, initial encounter |
| T39.2X4D | Poisoning by pyrazolone derivatives, undetermined, subsequent encounter |
| T39.2X4S | Poisoning by pyrazolone derivatives, undetermined, sequela |
| T39.2X5 | Adverse effect of pyrazolone derivatives |
| T39.2X5A | Adverse effect of pyrazolone derivatives, initial encounter |
| T39.2X5D | Adverse effect of pyrazolone derivatives, subsequent encounter |
| T39.2X5S | Adverse effect of pyrazolone derivatives, sequela |
| T39.2X6 | Underdosing of pyrazolone derivatives |
| T39.2X6A | Underdosing of pyrazolone derivatives, initial encounter |
| T39.2X6D | Underdosing of pyrazolone derivatives, subsequent encounter |
| T39.2X6S | Underdosing of pyrazolone derivatives, sequela |
| T39.3 | Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.31 | Poisoning by, adverse effect of and underdosing of propionic acid derivatives |
| T39.311 | Poisoning by propionic acid derivatives, accidental (unintentional) |
| T39.311A | Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter |
| T39.311D | Poisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter |
| T39.311S | Poisoning by propionic acid derivatives, accidental (unintentional), sequela |
| T39.312 | Poisoning by propionic acid derivatives, intentional self-harm |
| T39.312A | Poisoning by propionic acid derivatives, intentional self-harm, initial encounter |
| T39.312D | Poisoning by propionic acid derivatives, intentional self-harm, subsequent encounter |
| T39.312S | Poisoning by propionic acid derivatives, intentional self-harm, sequela |
| T39.313 | Poisoning by propionic acid derivatives, assault |
| T39.313A | Poisoning by propionic acid derivatives, assault, initial encounter |
| T39.313D | Poisoning by propionic acid derivatives, assault, subsequent encounter |
| T39.313S | Poisoning by propionic acid derivatives, assault, sequela |
| T39.314 | Poisoning by propionic acid derivatives, undetermined |
| T39.314A | Poisoning by propionic acid derivatives, undetermined, initial encounter |
| T39.314D | Poisoning by propionic acid derivatives, undetermined, subsequent encounter |
| T39.314S | Poisoning by propionic acid derivatives, undetermined, sequela |
| T39.315 | Adverse effect of propionic acid derivatives |
| T39.315A | Adverse effect of propionic acid derivatives, initial encounter |
| T39.315D | Adverse effect of propionic acid derivatives, subsequent encounter |
| T39.315S | Adverse effect of propionic acid derivatives, sequela |
| T39.316 | Underdosing of propionic acid derivatives |
| T39.316A | Underdosing of propionic acid derivatives, initial encounter |
| T39.316D | Underdosing of propionic acid derivatives, subsequent encounter |
| T39.316S | Underdosing of propionic acid derivatives, sequela |
| T39.39 | Poisoning by, adverse effect of and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.391 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional) |
| T39.391A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter |
| T39.391D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter |
| T39.391S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), sequela |
| T39.392 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm |
| T39.392A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter |
| T39.392D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter |
| T39.392S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela |
| T39.393 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault |
| T39.393A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter |
| T39.393D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter |
| T39.393S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, sequela |
| T39.394 | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined |
| T39.394A | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter |
| T39.394D | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter |
| T39.394S | Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, sequela |
| T39.395 | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.395A | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
| T39.395D | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter |
| T39.395S | Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela |
| T39.396 | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] |
| T39.396A | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
| T39.396D | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter |
| T39.396S | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela |
| T39.4 | Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified |
| T39.4X | Poisoning by, adverse effect of and underdosing of antirheumatics, not elsewhere classified |
| T39.4X1 | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional) |
| T39.4X1A | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.4X1D | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter |
| T39.4X1S | Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela |
| T39.4X2 | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm |
| T39.4X2A | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.4X2D | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter |
| T39.4X2S | Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela |
| T39.4X3 | Poisoning by antirheumatics, not elsewhere classified, assault |
| T39.4X3A | Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter |
| T39.4X3D | Poisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter |
| T39.4X3S | Poisoning by antirheumatics, not elsewhere classified, assault, sequela |
| T39.4X4 | Poisoning by antirheumatics, not elsewhere classified, undetermined |
| T39.4X4A | Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter |
| T39.4X4D | Poisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter |
| T39.4X4S | Poisoning by antirheumatics, not elsewhere classified, undetermined, sequela |
| T39.4X5 | Adverse effect of antirheumatics, not elsewhere classified |
| T39.4X5A | Adverse effect of antirheumatics, not elsewhere classified, initial encounter |
| T39.4X5D | Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter |
| T39.4X5S | Adverse effect of antirheumatics, not elsewhere classified, sequela |
| T39.4X6 | Underdosing of antirheumatics, not elsewhere classified |
| T39.4X6A | Underdosing of antirheumatics, not elsewhere classified, initial encounter |
| T39.4X6D | Underdosing of antirheumatics, not elsewhere classified, subsequent encounter |
| T39.4X6S | Underdosing of antirheumatics, not elsewhere classified, sequela |
| T39.8 | Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X | Poisoning by, adverse effect of and underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X1 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional) |
| T39.8X1A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.8X1D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter |
| T39.8X1S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), sequela |
| T39.8X2 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm |
| T39.8X2A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.8X2D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter |
| T39.8X2S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela |
| T39.8X3 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault |
| T39.8X3A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter |
| T39.8X3D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter |
| T39.8X3S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, sequela |
| T39.8X4 | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined |
| T39.8X4A | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter |
| T39.8X4D | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter |
| T39.8X4S | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, sequela |
| T39.8X5 | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X5A | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
| T39.8X5D | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter |
| T39.8X5S | Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela |
| T39.8X6 | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified |
| T39.8X6A | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
| T39.8X6D | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter |
| T39.8X6S | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela |
| T39.9 | Poisoning by, adverse effect of and underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.91 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional) |
| T39.91XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter |
| T39.91XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter |
| T39.91XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela |
| T39.92 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm |
| T39.92XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter |
| T39.92XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter |
| T39.92XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela |
| T39.93 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault |
| T39.93XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter |
| T39.93XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter |
| T39.93XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela |
| T39.94 | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined |
| T39.94XA | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter |
| T39.94XD | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter |
| T39.94XS | Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela |
| T39.95 | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.95XA | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
| T39.95XD | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter |
| T39.95XS | Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela |
| T39.96 | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic |
| T39.96XA | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
| T39.96XD | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter |
| T39.96XS | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela |
| T40.0 | Poisoning by, adverse effect of and underdosing of opium |
| T40.0X | Poisoning by, adverse effect of and underdosing of opium |
| T40.0X1 | Poisoning by opium, accidental (unintentional) |
| T40.0X1A | Poisoning by opium, accidental (unintentional), initial encounter |
| T40.0X1D | Poisoning by opium, accidental (unintentional), subsequent encounter |
| T40.0X1S | Poisoning by opium, accidental (unintentional), sequela |
| T40.0X2 | Poisoning by opium, intentional self-harm |
| T40.0X2A | Poisoning by opium, intentional self-harm, initial encounter |
| T40.0X2D | Poisoning by opium, intentional self-harm, subsequent encounter |
| T40.0X2S | Poisoning by opium, intentional self-harm, sequela |
| T40.0X3 | Poisoning by opium, assault |
| T40.0X3A | Poisoning by opium, assault, initial encounter |
| T40.0X3D | Poisoning by opium, assault, subsequent encounter |
| T40.0X3S | Poisoning by opium, assault, sequela |
| T40.0X4 | Poisoning by opium, undetermined |
| T40.0X4A | Poisoning by opium, undetermined, initial encounter |
| T40.0X4D | Poisoning by opium, undetermined, subsequent encounter |
| T40.0X4S | Poisoning by opium, undetermined, sequela |
| T40.0X5 | Adverse effect of opium |
| T40.0X5A | Adverse effect of opium, initial encounter |
| T40.0X5D | Adverse effect of opium, subsequent encounter |
| T40.0X5S | Adverse effect of opium, sequela |
| T40.0X6 | Underdosing of opium |
| T40.0X6A | Underdosing of opium, initial encounter |
| T40.0X6D | Underdosing of opium, subsequent encounter |
| T40.0X6S | Underdosing of opium, sequela |
| T40.1 | Poisoning by and adverse effect of heroin |
| T40.1X | Poisoning by and adverse effect of heroin |
| T40.1X1 | Poisoning by heroin, accidental (unintentional) |
| T40.1X1A | Poisoning by heroin, accidental (unintentional), initial encounter |
| T40.1X1D | Poisoning by heroin, accidental (unintentional), subsequent encounter |
| T40.1X1S | Poisoning by heroin, accidental (unintentional), sequela |
| T40.1X2 | Poisoning by heroin, intentional self-harm |
| T40.1X2A | Poisoning by heroin, intentional self-harm, initial encounter |
| T40.1X2D | Poisoning by heroin, intentional self-harm, subsequent encounter |
| T40.1X2S | Poisoning by heroin, intentional self-harm, sequela |
| T40.1X3 | Poisoning by heroin, assault |
| T40.1X3A | Poisoning by heroin, assault, initial encounter |
| T40.1X3D | Poisoning by heroin, assault, subsequent encounter |
| T40.1X3S | Poisoning by heroin, assault, sequela |
| T40.1X4 | Poisoning by heroin, undetermined |
| T40.1X4A | Poisoning by heroin, undetermined, initial encounter |
| T40.1X4D | Poisoning by heroin, undetermined, subsequent encounter |
| T40.1X4S | Poisoning by heroin, undetermined, sequela |
| T40.2 | Poisoning by, adverse effect of and underdosing of other opioids |
| T40.2X | Poisoning by, adverse effect of and underdosing of other opioids |
| T40.2X1 | Poisoning by other opioids, accidental (unintentional) |
| T40.2X1A | Poisoning by other opioids, accidental (unintentional), initial encounter |
| T40.2X1D | Poisoning by other opioids, accidental (unintentional), subsequent encounter |
| T40.2X1S | Poisoning by other opioids, accidental (unintentional), sequela |
| T40.2X2 | Poisoning by other opioids, intentional self-harm |
| T40.2X2A | Poisoning by other opioids, intentional self-harm, initial encounter |
| T40.2X2D | Poisoning by other opioids, intentional self-harm, subsequent encounter |
| T40.2X2S | Poisoning by other opioids, intentional self-harm, sequela |
| T40.2X3 | Poisoning by other opioids, assault |
| T40.2X3A | Poisoning by other opioids, assault, initial encounter |
| T40.2X3D | Poisoning by other opioids, assault, subsequent encounter |
| T40.2X3S | Poisoning by other opioids, assault, sequela |
| T40.2X4 | Poisoning by other opioids, undetermined |
| T40.2X4A | Poisoning by other opioids, undetermined, initial encounter |
| T40.2X4D | Poisoning by other opioids, undetermined, subsequent encounter |
| T40.2X4S | Poisoning by other opioids, undetermined, sequela |
| T40.2X5 | Adverse effect of other opioids |
| T40.2X5A | Adverse effect of other opioids, initial encounter |
| T40.2X5D | Adverse effect of other opioids, subsequent encounter |
| T40.2X5S | Adverse effect of other opioids, sequela |
| T40.2X6 | Underdosing of other opioids |
| T40.2X6A | Underdosing of other opioids, initial encounter |
| T40.2X6D | Underdosing of other opioids, subsequent encounter |
| T40.2X6S | Underdosing of other opioids, sequela |
| T40.3 | Poisoning by, adverse effect of and underdosing of methadone |
| T40.3X | Poisoning by, adverse effect of and underdosing of methadone |
| T40.3X1 | Poisoning by methadone, accidental (unintentional) |
| T40.3X1A | Poisoning by methadone, accidental (unintentional), initial encounter |
| T40.3X1D | Poisoning by methadone, accidental (unintentional), subsequent encounter |
| T40.3X1S | Poisoning by methadone, accidental (unintentional), sequela |
| T40.3X2 | Poisoning by methadone, intentional self-harm |
| T40.3X2A | Poisoning by methadone, intentional self-harm, initial encounter |
| T40.3X2D | Poisoning by methadone, intentional self-harm, subsequent encounter |
| T40.3X2S | Poisoning by methadone, intentional self-harm, sequela |
| T40.3X3 | Poisoning by methadone, assault |
| T40.3X3A | Poisoning by methadone, assault, initial encounter |
| T40.3X3D | Poisoning by methadone, assault, subsequent encounter |
| T40.3X3S | Poisoning by methadone, assault, sequela |
| T40.3X4 | Poisoning by methadone, undetermined |
| T40.3X4A | Poisoning by methadone, undetermined, initial encounter |
| T40.3X4D | Poisoning by methadone, undetermined, subsequent encounter |
| T40.3X4S | Poisoning by methadone, undetermined, sequela |
| T40.3X5 | Adverse effect of methadone |
| T40.3X5A | Adverse effect of methadone, initial encounter |
| T40.3X5D | Adverse effect of methadone, subsequent encounter |
| T40.3X5S | Adverse effect of methadone, sequela |
| T40.3X6 | Underdosing of methadone |
| T40.3X6A | Underdosing of methadone, initial encounter |
| T40.3X6D | Underdosing of methadone, subsequent encounter |
| T40.3X6S | Underdosing of methadone, sequela |
| T40.4 | Poisoning by, adverse effect of and underdosing of other synthetic narcotics |
| T40.41 | Poisoning by, adverse effect of and underdosing of fentanyl or fentanyl analogs |
| T40.411 | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional) |
| T40.411A | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter |
| T40.411D | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), subsequent encounter |
| T40.411S | Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), sequela |
| T40.412 | Poisoning by fentanyl or fentanyl analogs, intentional self-harm |
| T40.412A | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter |
| T40.412D | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, subsequent encounter |
| T40.412S | Poisoning by fentanyl or fentanyl analogs, intentional self-harm, sequela |
| T40.413 | Poisoning by fentanyl or fentanyl analogs, assault |
| T40.413A | Poisoning by fentanyl or fentanyl analogs, assault, initial encounter |
| T40.413D | Poisoning by fentanyl or fentanyl analogs, assault, subsequent encounter |
| T40.413S | Poisoning by fentanyl or fentanyl analogs, assault, sequela |
| T40.414 | Poisoning by fentanyl or fentanyl analogs, undetermined |
| T40.414A | Poisoning by fentanyl or fentanyl analogs, undetermined, initial encounter |
| T40.414D | Poisoning by fentanyl or fentanyl analogs, undetermined, subsequent encounter |
| T40.414S | Poisoning by fentanyl or fentanyl analogs, undetermined, sequela |
| T40.415 | Adverse effect of fentanyl or fentanyl analogs |
| T40.415A | Adverse effect of fentanyl or fentanyl analogs, initial encounter |
| T40.415D | Adverse effect of fentanyl or fentanyl analogs, subsequent encounter |
| T40.415S | Adverse effect of fentanyl or fentanyl analogs, sequela |
| T40.416 | Underdosing of fentanyl or fentanyl analogs |
| T40.416A | Underdosing of fentanyl or fentanyl analogs, initial encounter |
| T40.416D | Underdosing of fentanyl or fentanyl analogs, subsequent encounter |
| T40.416S | Underdosing of fentanyl or fentanyl analogs, sequela |
| T40.42 | Poisoning by, adverse effect of and underdosing of tramadol |
| T40.421 | Poisoning by tramadol, accidental (unintentional) |
| T40.421A | Poisoning by tramadol, accidental (unintentional), initial encounter |
| T40.421D | Poisoning by tramadol, accidental (unintentional), subsequent encounter |
| T40.421S | Poisoning by tramadol, accidental (unintentional), sequela |
| T40.422 | Poisoning by tramadol, intentional self-harm |
| T40.422A | Poisoning by tramadol, intentional self-harm, initial encounter |
| T40.422D | Poisoning by tramadol, intentional self-harm, subsequent encounter |
| T40.422S | Poisoning by tramadol, intentional self-harm, sequela |
| T40.423 | Poisoning by tramadol, assault |
| T40.423A | Poisoning by tramadol, assault, initial encounter |
| T40.423D | Poisoning by tramadol, assault, subsequent encounter |
| T40.423S | Poisoning by tramadol, assault, sequela |
| T40.424 | Poisoning by tramadol, undetermined |
| T40.424A | Poisoning by tramadol, undetermined, initial encounter |
| T40.424D | Poisoning by tramadol, undetermined, subsequent encounter |
| T40.424S | Poisoning by tramadol, undetermined, sequela |
| T40.425 | Adverse effect of tramadol |
| T40.425A | Adverse effect of tramadol, initial encounter |
| T40.425D | Adverse effect of tramadol, subsequent encounter |
| T40.425S | Adverse effect of tramadol, sequela |
| T40.426 | Underdosing of tramadol |
| T40.426A | Underdosing of tramadol, initial encounter |
| T40.426D | Underdosing of tramadol, subsequent encounter |
| T40.426S | Underdosing of tramadol, sequela |
| T40.49 | Poisoning by, adverse effect of and underdosing of other synthetic narcotics |
| T40.491 | Poisoning by other synthetic narcotics, accidental (unintentional) |
| T40.491A | Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter |
| T40.491D | Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter |
| T40.491S | Poisoning by other synthetic narcotics, accidental (unintentional), sequela |
| T40.492 | Poisoning by other synthetic narcotics, intentional self-harm |
| T40.492A | Poisoning by other synthetic narcotics, intentional self-harm, initial encounter |
| T40.492D | Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter |
| T40.492S | Poisoning by other synthetic narcotics, intentional self-harm, sequela |
| T40.493 | Poisoning by other synthetic narcotics, assault |
| T40.493A | Poisoning by other synthetic narcotics, assault, initial encounter |
| T40.493D | Poisoning by other synthetic narcotics, assault, subsequent encounter |
| T40.493S | Poisoning by other synthetic narcotics, assault, sequela |
| T40.494 | Poisoning by other synthetic narcotics, undetermined |
| T40.494A | Poisoning by other synthetic narcotics, undetermined, initial encounter |
| T40.494D | Poisoning by other synthetic narcotics, undetermined, subsequent encounter |
| T40.494S | Poisoning by other synthetic narcotics, undetermined, sequela |
| T40.495 | Adverse effect of other synthetic narcotics |
| T40.495A | Adverse effect of other synthetic narcotics, initial encounter |
| T40.495D | Adverse effect of other synthetic narcotics, subsequent encounter |
| T40.495S | Adverse effect of other synthetic narcotics, sequela |
| T40.496 | Underdosing of other synthetic narcotics |
| T40.496A | Underdosing of other synthetic narcotics, initial encounter |
| T40.496D | Underdosing of other synthetic narcotics, subsequent encounter |
| T40.496S | Underdosing of other synthetic narcotics, sequela |
| T40.4X | |
| T40.4X1 | |
| T40.4X1A | |
| T40.4X1D | |
| T40.4X1S | |
| T40.4X2 | |
| T40.4X2A | |
| T40.4X2D | |
| T40.4X2S | |
| T40.4X3 | |
| T40.4X3A | |
| T40.4X3D | |
| T40.4X3S | |
| T40.4X4 | |
| T40.4X4A | |
| T40.4X4D | |
| T40.4X4S | |
| T40.4X5 | |
| T40.4X5A | |
| T40.4X5D | |
| T40.4X5S | |
| T40.4X6 | |
| T40.4X6A | |
| T40.4X6D | |
| T40.4X6S | |
| T40.5 | Poisoning by, adverse effect of and underdosing of cocaine |
| T40.5X | Poisoning by, adverse effect of and underdosing of cocaine |
| T40.5X1 | Poisoning by cocaine, accidental (unintentional) |
| T40.5X1A | Poisoning by cocaine, accidental (unintentional), initial encounter |
| T40.5X1D | Poisoning by cocaine, accidental (unintentional), subsequent encounter |
| T40.5X1S | Poisoning by cocaine, accidental (unintentional), sequela |
| T40.5X2 | Poisoning by cocaine, intentional self-harm |
| T40.5X2A | Poisoning by cocaine, intentional self-harm, initial encounter |
| T40.5X2D | Poisoning by cocaine, intentional self-harm, subsequent encounter |
| T40.5X2S | Poisoning by cocaine, intentional self-harm, sequela |
| T40.5X3 | Poisoning by cocaine, assault |
| T40.5X3A | Poisoning by cocaine, assault, initial encounter |
| T40.5X3D | Poisoning by cocaine, assault, subsequent encounter |
| T40.5X3S | Poisoning by cocaine, assault, sequela |
| T40.5X4 | Poisoning by cocaine, undetermined |
| T40.5X4A | Poisoning by cocaine, undetermined, initial encounter |
| T40.5X4D | Poisoning by cocaine, undetermined, subsequent encounter |
| T40.5X4S | Poisoning by cocaine, undetermined, sequela |
| T40.5X5 | Adverse effect of cocaine |
| T40.5X5A | Adverse effect of cocaine, initial encounter |
| T40.5X5D | Adverse effect of cocaine, subsequent encounter |
| T40.5X5S | Adverse effect of cocaine, sequela |
| T40.5X6 | Underdosing of cocaine |
| T40.5X6A | Underdosing of cocaine, initial encounter |
| T40.5X6D | Underdosing of cocaine, subsequent encounter |
| T40.5X6S | Underdosing of cocaine, sequela |
| T40.6 | Poisoning by, adverse effect of and underdosing of other and unspecified narcotics |
| T40.60 | Poisoning by, adverse effect of and underdosing of unspecified narcotics |
| T40.601 | Poisoning by unspecified narcotics, accidental (unintentional) |
| T40.601A | Poisoning by unspecified narcotics, accidental (unintentional), initial encounter |
| T40.601D | Poisoning by unspecified narcotics, accidental (unintentional), subsequent encounter |
| T40.601S | Poisoning by unspecified narcotics, accidental (unintentional), sequela |
| T40.602 | Poisoning by unspecified narcotics, intentional self-harm |
| T40.602A | Poisoning by unspecified narcotics, intentional self-harm, initial encounter |
| T40.602D | Poisoning by unspecified narcotics, intentional self-harm, subsequent encounter |
| T40.602S | Poisoning by unspecified narcotics, intentional self-harm, sequela |
| T40.603 | Poisoning by unspecified narcotics, assault |
| T40.603A | Poisoning by unspecified narcotics, assault, initial encounter |
| T40.603D | Poisoning by unspecified narcotics, assault, subsequent encounter |
| T40.603S | Poisoning by unspecified narcotics, assault, sequela |
| T40.604 | Poisoning by unspecified narcotics, undetermined |
| T40.604A | Poisoning by unspecified narcotics, undetermined, initial encounter |
| T40.604D | Poisoning by unspecified narcotics, undetermined, subsequent encounter |
| T40.604S | Poisoning by unspecified narcotics, undetermined, sequela |
| T40.605 | Adverse effect of unspecified narcotics |
| T40.605A | Adverse effect of unspecified narcotics, initial encounter |
| T40.605D | Adverse effect of unspecified narcotics, subsequent encounter |
| T40.605S | Adverse effect of unspecified narcotics, sequela |
| T40.606 | Underdosing of unspecified narcotics |
| T40.606A | Underdosing of unspecified narcotics, initial encounter |
| T40.606D | Underdosing of unspecified narcotics, subsequent encounter |
| T40.606S | Underdosing of unspecified narcotics, sequela |
| T40.69 | Poisoning by, adverse effect of and underdosing of other narcotics |
| T40.691 | Poisoning by other narcotics, accidental (unintentional) |
| T40.691A | Poisoning by other narcotics, accidental (unintentional), initial encounter |
| T40.691D | Poisoning by other narcotics, accidental (unintentional), subsequent encounter |
| T40.691S | Poisoning by other narcotics, accidental (unintentional), sequela |
| T40.692 | Poisoning by other narcotics, intentional self-harm |
| T40.692A | Poisoning by other narcotics, intentional self-harm, initial encounter |
| T40.692D | Poisoning by other narcotics, intentional self-harm, subsequent encounter |
| T40.692S | Poisoning by other narcotics, intentional self-harm, sequela |
| T40.693 | Poisoning by other narcotics, assault |
| T40.693A | Poisoning by other narcotics, assault, initial encounter |
| T40.693D | Poisoning by other narcotics, assault, subsequent encounter |
| T40.693S | Poisoning by other narcotics, assault, sequela |
| T40.694 | Poisoning by other narcotics, undetermined |
| T40.694A | Poisoning by other narcotics, undetermined, initial encounter |
| T40.694D | Poisoning by other narcotics, undetermined, subsequent encounter |
| T40.694S | Poisoning by other narcotics, undetermined, sequela |
| T40.695 | Adverse effect of other narcotics |
| T40.695A | Adverse effect of other narcotics, initial encounter |
| T40.695D | Adverse effect of other narcotics, subsequent encounter |
| T40.695S | Adverse effect of other narcotics, sequela |
| T40.696 | Underdosing of other narcotics |
| T40.696A | Underdosing of other narcotics, initial encounter |
| T40.696D | Underdosing of other narcotics, subsequent encounter |
| T40.696S | Underdosing of other narcotics, sequela |
| T40.7 | Poisoning by, adverse effect of and underdosing of cannabis (derivatives) |
| T40.7X | Poisoning by, adverse effect of and underdosing of cannabis (derivatives) |
| T40.7X1 | Poisoning by cannabis (derivatives), accidental (unintentional) |
| T40.7X1A | Poisoning by cannabis (derivatives), accidental (unintentional), initial encounter |
| T40.7X1D | Poisoning by cannabis (derivatives), accidental (unintentional), subsequent encounter |
| T40.7X1S | Poisoning by cannabis (derivatives), accidental (unintentional), sequela |
| T40.7X2 | Poisoning by cannabis (derivatives), intentional self-harm |
| T40.7X2A | Poisoning by cannabis (derivatives), intentional self-harm, initial encounter |
| T40.7X2D | Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter |
| T40.7X2S | Poisoning by cannabis (derivatives), intentional self-harm, sequela |
| T40.7X3 | Poisoning by cannabis (derivatives), assault |
| T40.7X3A | Poisoning by cannabis (derivatives), assault, initial encounter |
| T40.7X3D | Poisoning by cannabis (derivatives), assault, subsequent encounter |
| T40.7X3S | Poisoning by cannabis (derivatives), assault, sequela |
| T40.7X4 | Poisoning by cannabis (derivatives), undetermined |
| T40.7X4A | Poisoning by cannabis (derivatives), undetermined, initial encounter |
| T40.7X4D | Poisoning by cannabis (derivatives), undetermined, subsequent encounter |
| T40.7X4S | Poisoning by cannabis (derivatives), undetermined, sequela |
| T40.7X5 | Adverse effect of cannabis (derivatives) |
| T40.7X5A | Adverse effect of cannabis (derivatives), initial encounter |
| T40.7X5D | Adverse effect of cannabis (derivatives), subsequent encounter |
| T40.7X5S | Adverse effect of cannabis (derivatives), sequela |
| T40.7X6 | Underdosing of cannabis (derivatives) |
| T40.7X6A | Underdosing of cannabis (derivatives), initial encounter |
| T40.7X6D | Underdosing of cannabis (derivatives), subsequent encounter |
| T40.7X6S | Underdosing of cannabis (derivatives), sequela |
| T40.8 | Poisoning by and adverse effect of lysergide [LSD] |
| T40.8X | Poisoning by and adverse effect of lysergide [LSD] |
| T40.8X1 | Poisoning by lysergide [LSD], accidental (unintentional) |
| T40.8X1A | Poisoning by lysergide [LSD], accidental (unintentional), initial encounter |
| T40.8X1D | Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter |
| T40.8X1S | Poisoning by lysergide [LSD], accidental (unintentional), sequela |
| T40.8X2 | Poisoning by lysergide [LSD], intentional self-harm |
| T40.8X2A | Poisoning by lysergide [LSD], intentional self-harm, initial encounter |
| T40.8X2D | Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter |
| T40.8X2S | Poisoning by lysergide [LSD], intentional self-harm, sequela |
| T40.8X3 | Poisoning by lysergide [LSD], assault |
| T40.8X3A | Poisoning by lysergide [LSD], assault, initial encounter |
| T40.8X3D | Poisoning by lysergide [LSD], assault, subsequent encounter |
| T40.8X3S | Poisoning by lysergide [LSD], assault, sequela |
| T40.8X4 | Poisoning by lysergide [LSD], undetermined |
| T40.8X4A | Poisoning by lysergide [LSD], undetermined, initial encounter |
| T40.8X4D | Poisoning by lysergide [LSD], undetermined, subsequent encounter |
| T40.8X4S | Poisoning by lysergide [LSD], undetermined, sequela |
| T40.9 | Poisoning by, adverse effect of and underdosing of other and unspecified psychodysleptics [hallucinogens] |
| T40.90 | Poisoning by, adverse effect of and underdosing of unspecified psychodysleptics [hallucinogens] |
| T40.901 | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional) |
| T40.901A | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.901D | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter |
| T40.901S | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), sequela |
| T40.902 | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm |
| T40.902A | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.902D | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter |
| T40.902S | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela |
| T40.903 | Poisoning by unspecified psychodysleptics [hallucinogens], assault |
| T40.903A | Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter |
| T40.903D | Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter |
| T40.903S | Poisoning by unspecified psychodysleptics [hallucinogens], assault, sequela |
| T40.904 | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined |
| T40.904A | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter |
| T40.904D | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter |
| T40.904S | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, sequela |
| T40.905 | Adverse effect of unspecified psychodysleptics [hallucinogens] |
| T40.905A | Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter |
| T40.905D | Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter |
| T40.905S | Adverse effect of unspecified psychodysleptics [hallucinogens], sequela |
| T40.906 | Underdosing of unspecified psychodysleptics [hallucinogens] |
| T40.906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter |
| T40.906D | Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter |
| T40.906S | Underdosing of unspecified psychodysleptics [hallucinogens], sequela |
| T40.99 | Poisoning by, adverse effect of and underdosing of other psychodysleptics [hallucinogens] |
| T40.991 | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional) |
| T40.991A | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.991D | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter |
| T40.991S | Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), sequela |
| T40.992 | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm |
| T40.992A | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.992D | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter |
| T40.992S | Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, sequela |
| T40.993 | Poisoning by other psychodysleptics [hallucinogens], assault |
| T40.993A | Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter |
| T40.993D | Poisoning by other psychodysleptics [hallucinogens], assault, subsequent encounter |
| T40.993S | Poisoning by other psychodysleptics [hallucinogens], assault, sequela |
| T40.994 | Poisoning by other psychodysleptics [hallucinogens], undetermined |
| T40.994A | Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter |
| T40.994D | Poisoning by other psychodysleptics [hallucinogens], undetermined, subsequent encounter |
| T40.994S | Poisoning by other psychodysleptics [hallucinogens], undetermined, sequela |
| T40.995 | Adverse effect of other psychodysleptics [hallucinogens] |
| T40.995A | Adverse effect of other psychodysleptics [hallucinogens], initial encounter |
| T40.995D | Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter |
| T40.995S | Adverse effect of other psychodysleptics [hallucinogens], sequela |
| T40.996 | Underdosing of other psychodysleptics [hallucinogens] |
| T40.996A | Underdosing of other psychodysleptics [hallucinogens], initial encounter |
| T40.996D | Underdosing of other psychodysleptics [hallucinogens], subsequent encounter |
| T40.996S | Underdosing of other psychodysleptics [hallucinogens], sequela |
| T86.0 | Complications of bone marrow transplant |
| T86.00 | Unspecified complication of bone marrow transplant |
| T86.01 | Bone marrow transplant rejection |
| T86.02 | Bone marrow transplant failure |
| T86.03 | Bone marrow transplant infection |
| T86.09 | Other complications of bone marrow transplant |
| T86.1 | Complications of kidney transplant |
| T86.10 | Unspecified complication of kidney transplant |
| T86.11 | Kidney transplant rejection |
| T86.12 | Kidney transplant failure |
| T86.13 | Kidney transplant infection |
| T86.19 | Other complication of kidney transplant |
| T86.2 | Complications of heart transplant |
| T86.20 | Unspecified complication of heart transplant |
| T86.21 | Heart transplant rejection |
| T86.22 | Heart transplant failure |
| T86.23 | Heart transplant infection |
| T86.29 | Other complications of heart transplant |
| T86.290 | Cardiac allograft vasculopathy |
| T86.298 | Other complications of heart transplant |
| T86.3 | Complications of heart-lung transplant |
| T86.30 | Unspecified complication of heart-lung transplant |
| T86.31 | Heart-lung transplant rejection |
| T86.32 | Heart-lung transplant failure |
| T86.33 | Heart-lung transplant infection |
| T86.39 | Other complications of heart-lung transplant |
| T86.4 | Complications of liver transplant |
| T86.40 | Unspecified complication of liver transplant |
| T86.41 | Liver transplant rejection |
| T86.42 | Liver transplant failure |
| T86.43 | Liver transplant infection |
| T86.49 | Other complications of liver transplant |
| T86.5 | Complications of stem cell transplant |
| T86.8 | Complications of other transplanted organs and tissues |
| T86.81 | Complications of lung transplant |
| T86.810 | Lung transplant rejection |
| T86.811 | Lung transplant failure |
| T86.812 | Lung transplant infection |
| T86.818 | Other complications of lung transplant |
| T86.819 | Unspecified complication of lung transplant |
| T86.82 | Complications of skin graft (allograft) (autograft) |
| T86.820 | Skin graft (allograft) rejection |
| T86.821 | Skin graft (allograft) (autograft) failure |
| T86.822 | Skin graft (allograft) (autograft) infection |
| T86.828 | Other complications of skin graft (allograft) (autograft) |
| T86.829 | Unspecified complication of skin graft (allograft) (autograft) |
| T86.83 | Complications of bone graft |
| T86.830 | Bone graft rejection |
| T86.831 | Bone graft failure |
| T86.832 | Bone graft infection |
| T86.838 | Other complications of bone graft |
| T86.839 | Unspecified complication of bone graft |
| T86.84 | Complications of corneal transplant |
| T86.840 | Corneal transplant rejection |
| T86.8401 | Corneal transplant rejection, right eye |
| T86.8402 | Corneal transplant rejection, left eye |
| T86.8403 | Corneal transplant rejection, bilateral |
| T86.8409 | Corneal transplant rejection, unspecified eye |
| T86.841 | Corneal transplant failure |
| T86.8411 | Corneal transplant failure, right eye |
| T86.8412 | Corneal transplant failure, left eye |
| T86.8413 | Corneal transplant failure, bilateral |
| T86.8419 | Corneal transplant failure, unspecified eye |
| T86.842 | Corneal transplant infection |
| T86.8421 | Corneal transplant infection, right eye |
| T86.8422 | Corneal transplant infection, left eye |
| T86.8423 | Corneal transplant infection, bilateral |
| T86.8429 | Corneal transplant infection, unspecified eye |
| T86.848 | Other complications of corneal transplant |
| T86.8481 | Other complications of corneal transplant, right eye |
| T86.8482 | Other complications of corneal transplant, left eye |
| T86.8483 | Other complications of corneal transplant, bilateral |
| T86.8489 | Other complications of corneal transplant, unspecified eye |
| T86.849 | Unspecified complication of corneal transplant |
| T86.8491 | Unspecified complication of corneal transplant, right eye |
| T86.8492 | Unspecified complication of corneal transplant, left eye |
| T86.8493 | Unspecified complication of corneal transplant, bilateral |
| T86.8499 | Unspecified complication of corneal transplant, unspecified eye |
| T86.85 | Complication of intestine transplant |
| T86.850 | Intestine transplant rejection |
| T86.851 | Intestine transplant failure |
| T86.852 | Intestine transplant infection |
| T86.858 | Other complications of intestine transplant |
| T86.859 | Unspecified complication of intestine transplant |
| T86.89 | Complications of other transplanted tissue |
| T86.890 | Other transplanted tissue rejection |
| T86.891 | Other transplanted tissue failure |
| T86.892 | Other transplanted tissue infection |
| T86.898 | Other complications of other transplanted tissue |
| T86.899 | Unspecified complication of other transplanted tissue |
| T86.9 | Complication of unspecified transplanted organ and tissue |
| T86.90 | Unspecified complication of unspecified transplanted organ and tissue |
| T86.91 | Unspecified transplanted organ and tissue rejection |
| T86.92 | Unspecified transplanted organ and tissue failure |
| T86.93 | Unspecified transplanted organ and tissue infection |
| T86.99 | Other complications of unspecified transplanted organ and tissue |
| Z00.0 | Encounter for general adult medical examination |
| Z00.00 | Encounter for general adult medical examination without abnormal findings |
| Z00.01 | Encounter for general adult medical examination with abnormal findings |
| Z00.1 | Encounter for newborn, infant and child health examinations |
| Z00.11 | Newborn health examination |
| Z00.110 | Health examination for newborn under 8 days old |
| Z00.111 | Health examination for newborn 8 to 28 days old |
| Z00.12 | Encounter for routine child health examination |
| Z00.121 | Encounter for routine child health examination with abnormal findings |
| Z00.129 | Encounter for routine child health examination without abnormal findings |
| Z00.2 | Encounter for examination for period of rapid growth in childhood |
| Z00.3 | Encounter for examination for adolescent development state |
| Z00.5 | Encounter for examination of potential donor of organ and tissue |
| Z00.6 | Encounter for examination for normal comparison and control in clinical research program |
| Z00.7 | Encounter for examination for period of delayed growth in childhood |
| Z00.70 | Encounter for examination for period of delayed growth in childhood without abnormal findings |
| Z00.71 | Encounter for examination for period of delayed growth in childhood with abnormal findings |
| Z00.8 | Encounter for other general examination |
| Z02.0 | Encounter for examination for admission to educational institution |
| Z02.1 | Encounter for pre-employment examination |
| Z02.2 | Encounter for examination for admission to residential institution |
| Z02.3 | Encounter for examination for recruitment to armed forces |
| Z02.4 | Encounter for examination for driving license |
| Z02.5 | Encounter for examination for participation in sport |
| Z02.6 | Encounter for examination for insurance purposes |
| Z02.7 | Encounter for issue of medical certificate |
| Z02.71 | Encounter for disability determination |
| Z02.79 | Encounter for issue of other medical certificate |
| Z02.8 | Encounter for other administrative examinations |
| Z02.81 | Encounter for paternity testing |
| Z02.82 | Encounter for adoption services |
| Z02.83 | Encounter for blood-alcohol and blood-drug test |
| Z02.89 | Encounter for other administrative examinations |
| Z02.9 | Encounter for administrative examinations, unspecified |
| Z04.1 | Encounter for examination and observation following transport accident |
| Z04.2 | Encounter for examination and observation following work accident |
| Z04.3 | Encounter for examination and observation following other accident |
| Z04.4 | Encounter for examination and observation following alleged rape |
| Z04.41 | Encounter for examination and observation following alleged adult rape |
| Z04.42 | Encounter for examination and observation following alleged child rape |
| Z04.6 | Encounter for general psychiatric examination, requested by authority |
| Z04.7 | Encounter for examination and observation following alleged physical abuse |
| Z04.71 | Encounter for examination and observation following alleged adult physical abuse |
| Z04.72 | Encounter for examination and observation following alleged child physical abuse |
| Z04.8 | Encounter for examination and observation for other specified reasons |
| Z04.81 | Encounter for examination and observation of victim following forced sexual exploitation |
| Z04.82 | Encounter for examination and observation of victim following forced labor exploitation |
| Z04.89 | Encounter for examination and observation for other specified reasons |
| Z04.9 | Encounter for examination and observation for unspecified reason |
| Z11.1 | Encounter for screening for respiratory tuberculosis |
| Z11.7 | Encounter for testing for latent tuberculosis infection |
| Z16.1 | Resistance to beta lactam antibiotics |
| Z16.10 | Resistance to unspecified beta lactam antibiotics |
| Z16.11 | Resistance to penicillins |
| Z16.12 | Extended spectrum beta lactamase (ESBL) resistance |
| Z16.19 | Resistance to other specified beta lactam antibiotics |
| Z16.2 | Resistance to other antibiotics |
| Z16.20 | Resistance to unspecified antibiotic |
| Z16.21 | Resistance to vancomycin |
| Z16.22 | Resistance to vancomycin related antibiotics |
| Z16.23 | Resistance to quinolones and fluoroquinolones |
| Z16.24 | Resistance to multiple antibiotics |
| Z16.29 | Resistance to other single specified antibiotic |
| Z16.3 | Resistance to other antimicrobial drugs |
| Z16.30 | Resistance to unspecified antimicrobial drugs |
| Z16.31 | Resistance to antiparasitic drug(s) |
| Z16.32 | Resistance to antifungal drug(s) |
| Z16.33 | Resistance to antiviral drug(s) |
| Z16.34 | Resistance to antimycobacterial drug(s) |
| Z16.341 | Resistance to single antimycobacterial drug |
| Z16.342 | Resistance to multiple antimycobacterial drugs |
| Z16.35 | Resistance to multiple antimicrobial drugs |
| Z16.39 | Resistance to other specified antimicrobial drug |
| Z20.0 | Contact with and (suspected) exposure to intestinal infectious diseases |
| Z20.01 | Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli) |
| Z20.09 | Contact with and (suspected) exposure to other intestinal infectious diseases |
| Z20.1 | Contact with and (suspected) exposure to tuberculosis |
| Z20.2 | Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission |
| Z20.3 | Contact with and (suspected) exposure to rabies |
| Z20.4 | Contact with and (suspected) exposure to rubella |
| Z20.5 | Contact with and (suspected) exposure to viral hepatitis |
| Z20.6 | Contact with and (suspected) exposure to human immunodeficiency virus [HIV] |
| Z20.7 | Contact with and (suspected) exposure to pediculosis, acariasis and other infestations |
| Z20.8 | Contact with and (suspected) exposure to other communicable diseases |
| Z20.81 | Contact with and (suspected) exposure to other bacterial communicable diseases |
| Z20.810 | Contact with and (suspected) exposure to anthrax |
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z20.818 | Contact with and (suspected) exposure to other bacterial communicable diseases |
| Z20.82 | Contact with and (suspected) exposure to other viral communicable diseases |
| Z20.820 | Contact with and (suspected) exposure to varicella |
| Z20.821 | Contact with and (suspected) exposure to Zika virus |
| Z20.828 | Contact with and (suspected) exposure to other viral communicable diseases |
| Z20.89 | Contact with and (suspected) exposure to other communicable diseases |
| Z20.9 | Contact with and (suspected) exposure to unspecified communicable disease |
| Z22.5 | |
| Z22.50 | |
| Z22.51 | |
| Z22.52 | |
| Z22.59 | |
| Z22.7 | Latent tuberculosis |
| Z32.01 | Encounter for pregnancy test, result positive |
| Z33.1 | Pregnant state, incidental |
| Z33.2 | Encounter for elective termination of pregnancy |
| Z33.3 | Pregnant state, gestational carrier |
| Z34.0 | Encounter for supervision of normal first pregnancy |
| Z34.00 | Encounter for supervision of normal first pregnancy, unspecified trimester |
| Z34.01 | Encounter for supervision of normal first pregnancy, first trimester |
| Z34.02 | Encounter for supervision of normal first pregnancy, second trimester |
| Z34.03 | Encounter for supervision of normal first pregnancy, third trimester |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z34.80 | Encounter for supervision of other normal pregnancy, unspecified trimester |
| Z34.81 | Encounter for supervision of other normal pregnancy, first trimester |
| Z34.82 | Encounter for supervision of other normal pregnancy, second trimester |
| Z34.83 | Encounter for supervision of other normal pregnancy, third trimester |
| Z34.9 | Encounter for supervision of normal pregnancy, unspecified |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester |
| Z34.91 | Encounter for supervision of normal pregnancy, unspecified, first trimester |
| Z34.92 | Encounter for supervision of normal pregnancy, unspecified, second trimester |
| Z34.93 | Encounter for supervision of normal pregnancy, unspecified, third trimester |
| Z36.0 | Encounter for antenatal screening for chromosomal anomalies |
| Z36.1 | Encounter for antenatal screening for raised alphafetoprotein level |
| Z36.2 | Encounter for other antenatal screening follow-up |
| Z36.3 | Encounter for antenatal screening for malformations |
| Z36.4 | Encounter for antenatal screening for fetal growth retardation |
| Z36.5 | Encounter for antenatal screening for isoimmunization |
| Z36.8 | Encounter for other antenatal screening |
| Z36.81 | Encounter for antenatal screening for hydrops fetalis |
| Z36.82 | Encounter for antenatal screening for nuchal translucency |
| Z36.83 | Encounter for fetal screening for congenital cardiac abnormalities |
| Z36.84 | Encounter for antenatal screening for fetal lung maturity |
| Z36.85 | Encounter for antenatal screening for Streptococcus B |
| Z36.86 | Encounter for antenatal screening for cervical length |
| Z36.87 | Encounter for antenatal screening for uncertain dates |
| Z36.88 | Encounter for antenatal screening for fetal macrosomia |
| Z36.89 | Encounter for other specified antenatal screening |
| Z36.8A | Encounter for antenatal screening for other genetic defects |
| Z36.9 | Encounter for antenatal screening, unspecified |
| Z67.1 | Type A blood |
| Z67.10 | Type A blood, Rh positive |
| Z67.11 | Type A blood, Rh negative |
| Z67.2 | Type B blood |
| Z67.20 | Type B blood, Rh positive |
| Z67.21 | Type B blood, Rh negative |
| Z67.3 | Type AB blood |
| Z67.30 | Type AB blood, Rh positive |
| Z67.31 | Type AB blood, Rh negative |
| Z67.4 | Type O blood |
| Z67.40 | Type O blood, Rh positive |
| Z67.41 | Type O blood, Rh negative |
| Z67.9 | Unspecified blood type |
| Z67.90 | Unspecified blood type, Rh positive |
| Z67.91 | Unspecified blood type, Rh negative |
| Z68.1 | Body mass index [BMI] 19.9 or less, adult |
| Z68.2 | Body mass index [BMI] 20-29, adult |
| Z68.20 | Body mass index [BMI] 20.0-20.9, adult |
| Z68.21 | Body mass index [BMI] 21.0-21.9, adult |
| Z68.22 | Body mass index [BMI] 22.0-22.9, adult |
| Z68.23 | Body mass index [BMI] 23.0-23.9, adult |
| Z68.24 | Body mass index [BMI] 24.0-24.9, adult |
| Z68.25 | Body mass index [BMI] 25.0-25.9, adult |
| Z68.26 | Body mass index [BMI] 26.0-26.9, adult |
| Z68.27 | Body mass index [BMI] 27.0-27.9, adult |
| Z68.28 | Body mass index [BMI] 28.0-28.9, adult |
| Z68.29 | Body mass index [BMI] 29.0-29.9, adult |
| Z68.3 | Body mass index [BMI] 30-39, adult |
| Z68.30 | Body mass index [BMI]30.0-30.9, adult |
| Z68.31 | Body mass index [BMI] 31.0-31.9, adult |
| Z68.32 | Body mass index [BMI] 32.0-32.9, adult |
| Z68.33 | Body mass index [BMI] 33.0-33.9, adult |
| Z68.34 | Body mass index [BMI] 34.0-34.9, adult |
| Z68.35 | Body mass index [BMI] 35.0-35.9, adult |
| Z68.36 | Body mass index [BMI] 36.0-36.9, adult |
| Z68.37 | Body mass index [BMI] 37.0-37.9, adult |
| Z68.38 | Body mass index [BMI] 38.0-38.9, adult |
| Z68.39 | Body mass index [BMI] 39.0-39.9, adult |
| Z68.4 | Body mass index [BMI] 40 or greater, adult |
| Z68.41 | Body mass index [BMI]40.0-44.9, adult |
| Z68.42 | Body mass index [BMI] 45.0-49.9, adult |
| Z68.43 | Body mass index [BMI] 50.0-59.9, adult |
| Z68.44 | Body mass index [BMI] 60.0-69.9, adult |
| Z68.45 | Body mass index [BMI] 70 or greater, adult |
| Z68.5 | Body mass index [BMI] pediatric |
| Z68.51 | Body mass index [BMI] pediatric, less than 5th percentile for age |
| Z68.52 | Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age |
| Z68.53 | Body mass index [BMI] pediatric, 85th percentile to less than 95th percentile for age |
| Z68.54 | Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age |
| Z77.0 | Contact with and (suspected) exposure to hazardous, chiefly nonmedicinal, chemicals |
| Z77.01 | Contact with and (suspected) exposure to hazardous metals |
| Z77.010 | Contact with and (suspected) exposure to arsenic |
| Z77.011 | Contact with and (suspected) exposure to lead |
| Z77.012 | Contact with and (suspected) exposure to uranium |
| Z77.018 | Contact with and (suspected) exposure to other hazardous metals |
| Z77.02 | Contact with and (suspected) exposure to hazardous aromatic compounds |
| Z77.020 | Contact with and (suspected) exposure to aromatic amines |
| Z77.021 | Contact with and (suspected) exposure to benzene |
| Z77.028 | Contact with and (suspected) exposure to other hazardous aromatic compounds |
| Z77.09 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals |
| Z77.090 | Contact with and (suspected) exposure to asbestos |
| Z77.098 | Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals |
| Z77.1 | Contact with and (suspected) exposure to environmental pollution and hazards in the physical environment |
| Z77.11 | Contact with and (suspected) exposure to environmental pollution |
| Z77.110 | Contact with and (suspected) exposure to air pollution |
| Z77.111 | Contact with and (suspected) exposure to water pollution |
| Z77.112 | Contact with and (suspected) exposure to soil pollution |
| Z77.118 | Contact with and (suspected) exposure to other environmental pollution |
| Z77.12 | Contact with and (suspected) exposure to hazards in the physical environment |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) |
| Z77.121 | Contact with and (suspected) exposure to harmful algae and algae toxins |
| Z77.122 | Contact with and (suspected) exposure to noise |
| Z77.123 | Contact with and (suspected) exposure to radon and other naturally occurring radiation |
| Z77.128 | Contact with and (suspected) exposure to other hazards in the physical environment |
| Z77.2 | Contact with and (suspected) exposure to other hazardous substances |
| Z77.21 | Contact with and (suspected) exposure to potentially hazardous body fluids |
| Z77.22 | Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic) |
| Z77.29 | Contact with and (suspected) exposure to other hazardous substances |
| Z77.9 | Other contact with and (suspected) exposures hazardous to health |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.5 | Long term (current) use of steroids |
| Z79.8 | Other long term (current) drug therapy |
| Z79.89 | Other long term (current) drug therapy |
| Z79.890 | Hormone replacement therapy |
| Z79.891 | Long term (current) use of opiate analgesic |
| Z79.899 | Other long term (current) drug therapy |
| Z84.0 | Family history of diseases of the skin and subcutaneous tissue |
| Z84.1 | Family history of disorders of kidney and ureter |
| Z84.2 | Family history of other diseases of the genitourinary system |
| Z84.3 | Family history of consanguinity |
| Z84.8 | Family history of other specified conditions |
| Z84.81 | Family history of carrier of genetic disease |
| Z84.82 | Family history of sudden infant death syndrome |
| Z84.89 | Family history of other specified conditions |
| Z85.0 | Personal history of malignant neoplasm of digestive organs |
| Z85.00 | Personal history of malignant neoplasm of unspecified digestive organ |
| Z85.01 | Personal history of malignant neoplasm of esophagus |
| Z85.02 | Personal history of malignant neoplasm of stomach |
| Z85.020 | Personal history of malignant carcinoid tumor of stomach |
| Z85.028 | Personal history of other malignant neoplasm of stomach |
| Z85.03 | Personal history of malignant neoplasm of large intestine |
| Z85.030 | Personal history of malignant carcinoid tumor of large intestine |
| Z85.038 | Personal history of other malignant neoplasm of large intestine |
| Z85.04 | Personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus |
| Z85.040 | Personal history of malignant carcinoid tumor of rectum |
| Z85.048 | Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus |
| Z85.05 | Personal history of malignant neoplasm of liver |
| Z85.06 | Personal history of malignant neoplasm of small intestine |
| Z85.060 | Personal history of malignant carcinoid tumor of small intestine |
| Z85.068 | Personal history of other malignant neoplasm of small intestine |
| Z85.07 | Personal history of malignant neoplasm of pancreas |
| Z85.09 | Personal history of malignant neoplasm of other digestive organs |
| Z85.1 | Personal history of malignant neoplasm of trachea, bronchus and lung |
| Z85.11 | Personal history of malignant neoplasm of bronchus and lung |
| Z85.110 | Personal history of malignant carcinoid tumor of bronchus and lung |
| Z85.118 | Personal history of other malignant neoplasm of bronchus and lung |
| Z85.12 | Personal history of malignant neoplasm of trachea |
| Z85.2 | Personal history of malignant neoplasm of other respiratory and intrathoracic organs |
| Z85.20 | Personal history of malignant neoplasm of unspecified respiratory organ |
| Z85.21 | Personal history of malignant neoplasm of larynx |
| Z85.22 | Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses |
| Z85.23 | Personal history of malignant neoplasm of thymus |
| Z85.230 | Personal history of malignant carcinoid tumor of thymus |
| Z85.238 | Personal history of other malignant neoplasm of thymus |
| Z85.29 | Personal history of malignant neoplasm of other respiratory and intrathoracic organs |
| Z85.3 | Personal history of malignant neoplasm of breast |
| Z85.4 | Personal history of malignant neoplasm of genital organs |
| Z85.40 | Personal history of malignant neoplasm of unspecified female genital organ |
| Z85.41 | Personal history of malignant neoplasm of cervix uteri |
| Z85.42 | Personal history of malignant neoplasm of other parts of uterus |
| Z85.43 | Personal history of malignant neoplasm of ovary |
| Z85.44 | Personal history of malignant neoplasm of other female genital organs |
| Z85.45 | Personal history of malignant neoplasm of unspecified male genital organ |
| Z85.46 | Personal history of malignant neoplasm of prostate |
| Z85.47 | Personal history of malignant neoplasm of testis |
| Z85.48 | Personal history of malignant neoplasm of epididymis |
| Z85.49 | Personal history of malignant neoplasm of other male genital organs |
| Z85.5 | Personal history of malignant neoplasm of urinary tract |
| Z85.50 | Personal history of malignant neoplasm of unspecified urinary tract organ |
| Z85.51 | Personal history of malignant neoplasm of bladder |
| Z85.52 | Personal history of malignant neoplasm of kidney |
| Z85.520 | Personal history of malignant carcinoid tumor of kidney |
| Z85.528 | Personal history of other malignant neoplasm of kidney |
| Z85.53 | Personal history of malignant neoplasm of renal pelvis |
| Z85.54 | Personal history of malignant neoplasm of ureter |
| Z85.59 | Personal history of malignant neoplasm of other urinary tract organ |
| Z85.6 | Personal history of leukemia |
| Z85.7 | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues |
| Z85.71 | Personal history of Hodgkin lymphoma |
| Z85.72 | Personal history of non-Hodgkin lymphomas |
| Z85.79 | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues |
| Z85.8 | Personal history of malignant neoplasms of other organs and systems |
| Z85.81 | Personal history of malignant neoplasm of lip, oral cavity, and pharynx |
| Z85.810 | Personal history of malignant neoplasm of tongue |
| Z85.818 | Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx |
| Z85.819 | Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx |
| Z85.82 | Personal history of malignant neoplasm of skin |
| Z85.820 | Personal history of malignant melanoma of skin |
| Z85.821 | Personal history of Merkel cell carcinoma |
| Z85.828 | Personal history of other malignant neoplasm of skin |
| Z85.83 | Personal history of malignant neoplasm of bone and soft tissue |
| Z85.830 | Personal history of malignant neoplasm of bone |
| Z85.831 | Personal history of malignant neoplasm of soft tissue |
| Z85.84 | Personal history of malignant neoplasm of eye and nervous tissue |
| Z85.840 | Personal history of malignant neoplasm of eye |
| Z85.841 | Personal history of malignant neoplasm of brain |
| Z85.848 | Personal history of malignant neoplasm of other parts of nervous tissue |
| Z85.85 | Personal history of malignant neoplasm of endocrine glands |
| Z85.850 | Personal history of malignant neoplasm of thyroid |
| Z85.858 | Personal history of malignant neoplasm of other endocrine glands |
| Z85.89 | Personal history of malignant neoplasm of other organs and systems |
| Z85.9 | Personal history of malignant neoplasm, unspecified |
| Z86.11 | Personal history of tuberculosis |
| Z86.15 | Personal history of latent tuberculosis infection |